Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3013201	s-b2miglo	mg/l (mg/l)	3033	5084	0.00%
3013201	s-b2miglo	— (—)	263	424	100.00%	Distribution not available
3013201	s-b2miglo	mg/l______ (mg/l)	234	683	0.00%

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Any event in cancer register

930

1186

4.64

319.23

1.8

3.59

3.37

mg/l

0.65

889

1140

Malignant neoplasm

1036

902

6.84

307.65

2.0

1.6

3.61

3.31

mg/l

0.99

992

868

Fever of other and unknown origin

876

1284

6.03

307.65

2.1

1.8

4.16

3.70

mg/l

1.50

838

1228

L04AX Other immunosuppressants

909

1785

5.21

307.65

2.8

1.5

3.77

3.68

mg/l

0.24

876

1714

Liquid cancers

1949

429

49.22

307.65

2.0

1.5

4.12

3.86

mg/l

0.59

1870

409

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

354

204

18.21

307.65

1.6

1.5

3.48

4.24

mg/l

1.34

345

193

Non-Hodgkin lymphoma, all, including Hilmo

579

167

38.31

307.65

1.6

1.5

3.63

4.41

mg/l

1.23

563

161

Second line medication for Crohn's disease

915

1814

5.15

307.65

2.7

1.5

3.76

3.66

mg/l

0.24

882

1743

Non-follicular lymphoma

379

307

13.54

307.65

1.6

1.8

3.90

4.56

mg/l

1.48

366

296

Secondary and unspecified malignant neoplasm of lymph nodes

322

107

32.87

307.65

1.6

1.5

3.48

4.20

mg/l

1.08

316

102

ILD medications: immunosuppressive drugs

1070

1462

6.78

307.65

2.6

1.5

3.96

3.43

mg/l

2.75

1032

1405

Liquid cancers, including Hilmo

1983

486

40.07

307.65

2.0

1.5

4.10

3.82

mg/l

0.66

1903

463

Malignant neoplasm, wide definition

1002

916

6.46

307.65

1.9

1.6

3.59

3.30

mg/l

0.99

960

881

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1337

1892

4.84

307.65

1.9

1.8

4.27

3.40

mg/l

7.00

1278

1821

Malignant neoplasm

1035

904

6.82

307.65

2.0

1.6

3.61

3.31

mg/l

1.00

992

869

ILD medications

1217

1581

4.20

307.65

2.1

1.5

3.93

3.57

mg/l

1.48

1167

1514

Secondary uncertain malignant neoplasm

356

167

22.53

307.65

1.5

3.54

4.61

mg/l

1.63

347

160

First line medication for Crohn's disease

1164

1497

4.23

307.65

2.1

1.4

4.05

3.50

mg/l

2.66

1109

1436

Primary_lymphoid and hematopoietic malignant neoplasms

1856

357

61.83

307.65

2.1

1.5

4.16

3.92

mg/l

0.46

1785

340

Enlarged lymph nodes

441

398

11.66

307.65

1.5

1.9

3.37

3.75

mg/l

1.10

430

381

Malignant neoplasm, including Hilmo

1003

907

6.54

307.65

1.9

1.6

3.61

3.28

mg/l

1.13

960

873

Other diseases of blood and blood-forming organs, wide

490

747

6.83

306.91

1.7

1.9

3.95

4.11

mg/l

0.29

466

721

Bacterial infection, other or unspecified, including avohilmo

814

1618

4.20

281.12

2.1

1.7

4.66

3.55

mg/l

7.19

775

1555

Bacterial infection, other or unspecified

775

1552

4.29

278.11

2.1

1.7

4.70

3.58

mg/l

6.73

739

1491

Sicca syndrome [Sjögren]

272

250

11.69

257.70

2.4

1.7

2.95

4.13

mg/l

3.40

262

244

Aplastic and other anaemias

693

1512

4.28

254.04

1.9

1.7

4.96

3.94

mg/l

4.91

658

1446

Other systemic involvement of connective tissue (FG)

453

775

5.90

245.72

2.2

1.7

3.21

3.99

mg/l

3.53

436

737

Other and unspecified anaemias

645

1430

4.32

241.38

1.9

1.7

4.96

3.99

mg/l

4.21

614

1368

Other anaemias

647

1439

4.30

239.98

1.9

1.7

4.95

3.98

mg/l

4.26

616

1376

Other bacterial diseases

1024

2065

3.32

238.67

2.1

1.7

4.58

3.34

mg/l

10.73

982

1985

ILD medications: prednisolone, methylprednisolone, prednisone

966

1571

3.45

224.33

1.8

1.5

3.96

3.58

mg/l

1.40

916

1505

Systemic connective tissue disorders

537

1201

4.58

220.09

2.2

1.7

3.26

4.11

mg/l

4.87

516

1144

Other systemic involvement of connective tissue

457

932

5.04

209.77

2.2

1.7

3.20

4.13

mg/l

5.13

440

893

Neoplasms

542

531

5.40

207.83

1.8

1.7

3.90

3.03

mg/l

2.90

524

507

Other bacterial diseases, including avohilmo

1001

2028

3.11

206.81

2.0

1.7

4.44

3.27

mg/l

10.24

956

1951

Transplanted organ and tissue status

247

283

9.20

198.72

3.1

1.9

4.47

3.80

mg/l

0.87

241

276

General symptoms and signs

927

1405

3.33

197.08

1.8

3.88

3.62

mg/l

0.77

885

1346

Agranulocytosis

249

330

7.90

177.54

1.9

1.8

3.92

4.41

mg/l

0.79

240

322

Pneumonias (Asthma/COPD co-morbidities)

948

2180

2.86

173.06

2.3

1.6

4.30

3.35

mg/l

7.02

912

2095

Oxycodone

536

1189

3.92

171.88

2.4

1.6

4.28

3.92

mg/l

0.80

518

1138

849

1612

3.11

171.50

2.3

1.5

4.32

3.42

mg/l

5.53

817

1555

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

849

1612

3.11

171.50

2.3

1.5

4.32

3.42

mg/l

5.53

817

1555

Influenza and pneumonia

971

2140

2.82

169.79

2.3

1.6

4.28

3.35

mg/l

6.71

932

2059

All pneumoniae

944

2202

2.81

166.16

2.3

1.6

4.30

3.37

mg/l

6.76

908

2116

Solid cancers

582

887

3.88

162.36

1.7

1.6

3.60

3.31

mg/l

0.80

561

853

Pneumonia, organism unspecified

865

2076

2.88

162.03

2.2

1.5

4.54

3.39

mg/l

7.70

827

1996

Solid cancers, including Hilmo

588

905

3.81

160.26

1.7

1.6

3.59

3.32

mg/l

0.73

566

870

Oral corticosteroids

963

2127

2.68

150.39

1.9

1.8

3.74

3.80

mg/l

0.16

911

2054

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

904

2259

2.69

147.70

2.3

1.6

4.43

3.35

mg/l

7.72

867

2173

Any gastric operation

550

705

3.94

147.05

1.8

1.6

3.97

3.14

mg/l

3.40

531

679

GASTRO-related operations

550

705

3.94

147.05

1.8

1.6

3.97

3.14

mg/l

3.40

531

679

Dental caries

335

684

4.71

140.35

2.8

1.8

4.98

3.79

mg/l

2.19

325

658

Other medical care

575

1511

3.24

138.32

2.0

1.8

4.53

3.51

mg/l

4.37

548

1444

Septicaemia

487

1295

3.48

134.13

2.2

1.7

5.50

3.65

mg/l

7.09

462

1240

Caries of dentine

302

620

4.79

130.03

2.9

1.7

4.66

3.84

mg/l

1.45

293

597

Explicit Sepsis, including avohilmo

516

1443

3.29

129.86

2.2

1.7

5.44

3.49

mg/l

8.50

491

1385

Inflammatory bowel disease treatment related agents

964

2156

2.50

129.60

1.8

3.74

3.80

mg/l

0.14

913

2080

Infections, IBD-co-morbidities

216

202

7.67

129.38

2.5

1.5

4.93

3.09

mg/l

4.12

203

195

Explicit Sepsis

509

1424

3.30

129.17

2.2

1.7

5.43

3.50

mg/l

8.31

484

1366

Purpura and other haemorrhagic conditions

229

423

5.58

117.94

1.9

1.8

4.20

4.48

mg/l

0.29

218

410

Renal failure

547

1570

3.01

116.90

2.1

1.8

8.50

3.23

mg/l

37.43

520

1500

Coagulation defects, purpura and other haemorrhagic conditions

280

634

4.52

113.31

1.9

1.8

3.98

4.22

mg/l

0.29

267

607

Renal tubulo-interstitial diseases

782

2335

2.47

111.31

2.0

1.8

6.46

2.89

mg/l

37.61

746

2241

Bacterial Sepsis

517

1439

3.01

109.76

2.1

1.7

5.92

3.53

mg/l

11.25

494

1380

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

167

250

6.98

106.81

1.7

1.8

3.57

4.52

mg/l

2.45

158

242

All chronic kidney diseases

562

1608

2.82

105.36

2.0

1.8

7.94

3.02

mg/l

35.18

535

1543

Persons encountering health services for specific procedures and health care

860

2162

2.36

105.00

1.9

1.8

4.48

3.22

mg/l

9.28

823

2070

Other septicaemia, including avohilmo

415

1213

3.25

103.94

2.0

1.7

5.75

3.67

mg/l

6.78

392

1160

Other septicaemia

408

1187

3.28

103.87

2.0

1.7

5.75

3.67

mg/l

6.60

385

1135

Polyarthropathies

623

1482

2.72

103.64

1.9

1.8

4.42

3.76

mg/l

1.96

593

1417

Autoimmune diseases related-to ILD

729

2549

2.41

100.97

2.0

1.8

3.32

3.86

mg/l

3.17

693

2451

Covid-19 confirmed case

419

1350

3.14

100.56

2.1

1.7

4.80

4.03

mg/l

1.77

404

1282

COPD/asthma related infections

786

1612

2.46

99.38

2.1

1.5

4.15

3.42

mg/l

3.87

748

1555

COPD/asthma/ILD related infections

786

1612

2.46

99.38

2.1

1.5

4.15

3.42

mg/l

3.87

748

1555

Autoimmune diseases excluding thyroid diseases

837

1942

2.35

98.69

1.9

1.8

3.49

3.86

mg/l

1.51

795

1868

Finngen Rheumatological endpoints

742

1720

2.46

98.05

1.9

1.7

3.56

3.74

mg/l

0.50

714

1647

All kidney diseases

803

2334

2.32

97.44

2.0

1.8

5.70

2.83

mg/l

31.37

769

2243

Thrombocytopenia, unspecified

150

225

6.96

95.77

1.5

1.9

4.51

4.65

mg/l

0.09

142

217

Heart failure, not strict

687

1893

2.46

94.70

2.1

1.7

5.46

3.30

mg/l

16.46

661

1818

Any reimbursement code in KELA

340

422

4.06

94.69

1.9

1.4

3.78

2.36

mg/l

6.20

327

407

L01XX Other antineoplastic agents

140

203

7.28

92.52

2.1

1.8

3.48

4.45

mg/l

2.59

140

197

Autoimmune diseases excluding thyroid diseases, strict definition

799

1890

2.31

91.15

1.9

1.8

3.50

3.86

mg/l

1.40

757

1818

Certain infectious and parasitic diseases

701

1424

2.48

90.42

1.9

1.6

4.26

3.25

mg/l

5.81

670

1373

Codes for special purposes

492

1877

2.62

84.86

2.1

1.7

4.64

3.78

mg/l

2.71

475

1784

Chronic kidney disease

352

1087

3.16

84.57

2.0

1.7

9.99

3.39

mg/l

29.25

329

1030

Provisional assignment of new diseases of uncertain etiology

491

1876

2.62

84.45

2.1

1.7

4.63

3.77

mg/l

2.69

474

1783

Abnormal findings on examination of blood, without diagnosis

490

1692

2.65

84.40

1.6

1.9

4.23

4.00

mg/l

0.38

466

1618

Basal cell carcinoma, including Hilmo

294

533

3.76

83.63

1.8

1.5

4.28

3.74

mg/l

0.99

281

509

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

621

2311

2.36

83.04

1.9

1.8

3.74

4.00

mg/l

0.83

602

2212

Gout

340

916

3.24

82.40

2.2

1.8

5.44

4.12

mg/l

3.04

329

871

Malaise and fatigue

414

1138

2.89

81.35

1.6

1.8

4.36

3.78

mg/l

1.60

390

1088

Malignant neoplasm of skin, including Hilmo

319

625

3.44

79.70

1.6

1.5

4.31

3.56

mg/l

1.67

306

597

Disorders of calcium metabolism

127

197

6.70

78.55

2.3

1.8

6.58

3.83

mg/l

5.42

118

188

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

293

552

3.61

78.54

1.7

1.5

4.03

3.71

mg/l

0.53

277

528

Implicit bacterial Sepsis

423

1324

2.77

78.44

2.0

1.7

6.25

3.61

mg/l

9.87

402

1271

Excluding asthma or asthma-COPD overlap

546

1056

2.61

77.74

1.9

1.5

4.13

3.47

mg/l

2.20

523

1017

Implicit Sepsis

629

2026

2.30

77.01

2.1

1.7

5.42

3.32

mg/l

13.47

604

1946

Acute renal failure

263

754

3.55

76.71

2.2

1.7

8.77

3.33

mg/l

16.48

254

716

Malignant neoplasm of skin

303

598

3.45

76.36

1.6

1.5

4.29

3.62

mg/l

1.46

291

570

Gout, FINNGEN

340

1138

3.01

75.84

2.2

1.7

5.44

4.16

mg/l

2.97

329

1083

COPD differential diagnosis

540

1053

2.58

75.72

1.9

1.5

4.08

3.45

mg/l

2.10

518

1014

Other pulmonary diagnosis

541

1056

2.58

75.70

2.0

1.5

4.10

3.47

mg/l

2.04

518

1017

ILD differential diagnosis

539

1052

2.58

75.44

1.9

1.5

4.08

3.45

mg/l

2.08

517

1013

Other malignant neoplasms of skin (=non-melanoma skin cancer)

279

528

3.61

75.11

1.7

1.5

4.02

3.76

mg/l

0.41

265

504

Osteopathies and chondropathies

518

1963

2.43

75.11

2.4

1.7

3.98

3.83

mg/l

0.33

496

1883

Implicit bacterial Sepsis, including avohilmo

446

1421

2.64

74.79

2.0

1.7

6.21

3.53

mg/l

11.00

425

1363

Implicit Sepsis, including avohilmo

653

2106

2.23

73.61

2.0

1.7

5.36

3.26

mg/l

13.79

628

2023

Basal cell carcinoma

271

514

3.62

73.34

1.8

1.5

4.12

3.74

mg/l

0.67

258

490

862

2139

2.05

72.53

2.2

1.6

4.05

3.75

mg/l

0.97

818

2062

Viral pneumonia

165

354

4.76

71.55

2.9

1.6

4.13

3.87

mg/l

0.32

155

340

Implicit viral Sepsis, including avohilmo

308

1034

3.01

68.91

2.3

1.7

5.11

3.56

mg/l

4.27

293

988

Hypercalcemia

103

148

7.34

68.70

2.3

1.7

6.18

3.86

mg/l

3.97

142

Disorders of mineral metabolism

137

263

5.36

67.84

2.3

1.8

6.30

3.62

mg/l

6.12

128

253

Implicit viral Sepsis

234

674

3.53

67.79

2.4

1.7

5.33

3.55

mg/l

3.89

221

644

Viral Sepsis

234

675

3.52

67.64

2.4

1.7

5.33

3.55

mg/l

3.91

221

645

Certain disorders involving the immune mechanism

222

621

3.64

67.32

1.9

1.8

4.54

4.06

mg/l

0.73

216

600

Reimbursement for rheumatic diseases

490

2102

2.34

66.08

1.9

1.8

3.30

3.85

mg/l

2.50

471

2018

Bronchitis

810

2470

1.98

64.38

2.2

1.7

3.92

3.79

mg/l

0.35

766

2376

Condition for Implicit Sepsis (Organ dysfunction codes)

645

2114

2.13

64.36

2.0

1.7

5.24

3.23

mg/l

12.89

621

2032

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

726

2280

2.02

62.25

2.0

1.7

4.02

3.62

mg/l

1.38

697

2187

Autoimmune diseases

768

1945

2.01

61.55

1.9

1.8

3.82

3.86

mg/l

0.07

730

1871

Heart failure,strict

472

1408

2.36

60.34

1.9

1.7

5.06

3.54

mg/l

8.86

448

1350

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

641

2107

2.06

59.01

2.0

1.7

4.85

3.18

mg/l

11.24

615

2026

Dialysis, with operation codes

158

387

4.17

58.00

2.1

1.8

13.08

3.13

mg/l

20.16

152

371

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

131

172

5.43

57.90

1.8

1.5

4.13

3.23

mg/l

1.24

124

165

Asthma, unspecified (mode), excluding more controls

343

924

2.67

57.29

1.7

1.5

3.62

3.25

mg/l

0.84

335

890

Abnormalities of breathing

620

1714

2.08

55.94

1.8

3.95

3.69

mg/l

0.67

589

1644

Opioids

639

1604

2.07

55.24

1.9

1.6

3.99

3.60

mg/l

1.12

610

1539

All influenza

235

771

3.08

55.06

3.3

1.6

4.14

3.68

mg/l

0.69

217

736

Examination and observation for other reasons

441

1049

2.39

54.80

1.9

1.7

3.69

3.77

mg/l

0.12

426

996

Abnormal findings on diagnostic imaging of lung

444

1882

2.26

54.67

1.9

1.8

3.92

4.15

mg/l

0.54

429

1797

Other heart diseases

319

761

2.74

54.48

2.1

1.8

4.40

2.72

mg/l

7.22

311

726

Used for control exclusion in common control thyroid runs

705

1811

1.97

53.39

1.9

1.8

3.99

3.83

mg/l

0.34

673

1741

Dyspnoea

680

2551

1.93

53.07

1.9

1.8

4.27

3.70

mg/l

2.12

644

2456

Viral infections characterized by skin and mucous membrane lesions

363

1535

2.38

51.48

2.1

1.8

3.70

3.76

mg/l

0.09

345

1470

Any death

540

1825

2.09

51.46

2.2

1.7

5.24

3.53

mg/l

9.02

514

1767

Asthma, unspecified (mode)

351

1023

2.49

51.12

1.7

1.5

3.61

3.45

mg/l

0.28

342

986

Headache

394

1318

2.32

50.08

1.9

1.8

3.39

3.57

mg/l

0.37

374

1264

Metabolic disorders

671

2101

1.92

49.67

1.9

1.8

4.58

3.48

mg/l

5.61

643

2009

Other heart diseases, wide

607

1855

1.99

49.46

2.0

1.8

4.11

3.30

mg/l

4.00

589

1775

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

656

2703

1.90

49.28

2.0

1.8

3.67

3.79

mg/l

0.30

626

2595

Tramadol

533

1549

2.08

48.82

1.8

1.6

3.98

3.63

mg/l

0.90

509

1488

Glomerular diseases

194

612

3.22

48.81

2.2

1.8

9.39

3.85

mg/l

11.13

182

587

Acute upper respiratory infections of multiple and unspecified sites

552

2010

2.01

48.53

2.2

1.6

3.81

3.67

mg/l

0.27

524

1934

Cardiovascular diseases (excluding rheumatic etc)

366

861

2.44

48.17

1.8

1.7

4.00

2.63

mg/l

5.40

356

820

Asthma, excluding more controls

422

942

2.31

47.68

1.7

1.5

3.57

3.26

mg/l

0.72

405

908

Hypertensive diseases (excluding secondary)

332

764

2.54

47.59

1.8

4.82

2.72

mg/l

8.25

323

731

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

146

379

3.77

46.78

1.7

1.5

3.99

3.95

mg/l

0.03

139

362

Nephropathy related operations

150

414

3.70

46.65

2.1

1.8

13.43

3.77

mg/l

17.92

144

398

Heart failure, strict

498

1685

2.07

46.52

1.9

1.8

5.22

3.93

mg/l

5.97

472

1616

Parasetamol

442

1012

2.22

45.34

1.8

1.6

4.04

3.67

mg/l

0.78

424

962

Other acute lower respiratory infections

413

1861

2.13

44.32

2.4

1.7

4.08

3.92

mg/l

0.30

394

1770

All-cause Heart Failure

485

1662

2.04

43.94

1.9

1.8

5.27

3.87

mg/l

6.75

460

1593

Acute upper respiratory infections

726

2427

1.80

43.81

2.2

1.7

3.88

3.83

mg/l

0.10

689

2334

Asthma

439

1045

2.18

43.34

1.7

1.5

3.58

3.46

mg/l

0.23

421

1008

Certain infectious and parasitic diseases, including avohilmo

446

1036

2.17

43.22

1.7

1.6

4.57

3.19

mg/l

6.12

427

998

Asthma (mode)

433

1052

2.17

42.77

1.7

1.5

3.46

3.45

mg/l

0.00

417

1013

Medical observation and evaluation for suspected diseases and conditions

441

1053

2.15

42.23

2.0

1.7

3.60

3.76

mg/l

0.31

419

999

Codeine

568

1592

1.94

41.83

1.7

1.6

3.75

3.61

mg/l

0.32

540

1530

Other bacterial intestinal infections

176

577

3.09

41.52

2.9

1.6

4.86

3.94

mg/l

1.11

162

553

Oedema, not elsewhere classified

236

884

2.63

41.21

2.0

1.8

4.55

3.84

mg/l

0.96

228

839

Pain, not elsewhere classified

201

712

2.85

41.17

1.5

1.8

3.83

3.71

mg/l

0.14

193

683

Symptoms and signs involving the skin and subcutaneous tissue

531

2662

1.89

41.10

2.0

1.8

3.46

3.82

mg/l

1.45

514

2548

Asthma (only as main-diagnosis), excluding more controls

379

942

2.23

40.68

1.7

1.5

3.20

3.26

mg/l

0.12

361

908

Cardiovascular diseases

320

706

2.42

40.36

1.9

1.8

3.90

2.56

mg/l

4.58

312

669

Bacterial intestinal infections, IBD co-morbidities

179

603

3.01

40.29

2.9

1.7

4.84

4.04

mg/l

0.92

166

582

Low back pain

534

1891

1.91

40.17

1.9

1.7

3.48

3.81

mg/l

0.95

508

1808

Enterocolitis due to Clostridium difficile

127

347

3.73

40.12

3.3

1.7

5.46

4.47

mg/l

0.80

119

334

Bacterial pneumonia (organism specified)

365

1553

2.14

39.62

3.0

1.6

4.38

4.07

mg/l

0.57

352

1476

Polyneuropathies and other disorders of the peripheral nervous system

216

816

2.68

39.27

2.0

1.7

4.05

4.42

mg/l

0.51

210

775

Zoster [herpes zoster]

189

667

2.87

39.15

2.2

1.8

3.51

4.18

mg/l

2.08

179

639

Venous thromboembolism

430

2093

1.99

38.75

2.3

1.7

4.04

4.02

mg/l

0.03

414

1999

Dorsalgia

647

1904

1.81

38.54

1.9

1.7

3.51

3.80

mg/l

1.02

616

1818

Chronic apical periodontitis

739

2408

1.73

38.31

2.0

1.7

3.90

3.77

mg/l

0.31

709

2304

Other arthritis (FG)

242

978

2.50

38.19

2.1

1.7

4.08

3.87

mg/l

0.25

230

936

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

186

293

3.20

37.99

1.8

1.9

4.09

3.07

mg/l

1.92

181

279

Complications of surgical and medical care, not elsewhere classified

682

2637

1.73

37.10

1.8

4.28

3.70

mg/l

1.90

657

2524

Bacterial pneumoniae

301

1179

2.26

36.96

3.1

1.5

4.43

3.64

mg/l

1.99

289

1130

Other disorders of lacrimal gland

312

1429

2.20

36.93

1.9

1.8

3.64

3.89

mg/l

0.48

300

1369

Diseases of the respiratory system

386

903

2.15

36.91

1.9

1.5

4.29

3.46

mg/l

2.60

371

871

Heart failure and antihypertensive medication

217

525

2.71

36.38

2.1

1.9

5.51

3.09

mg/l

7.32

208

508

Intestinal infectious diseases

636

2719

1.75

36.34

2.2

1.7

4.37

3.66

mg/l

2.61

602

2612

Acute bronchitis

320

1462

2.16

36.11

2.2

1.7

4.16

4.03

mg/l

0.20

305

1386

DVT of lower extremities and pulmonary embolism

345

1655

2.09

35.80

2.4

1.7

4.08

4.18

mg/l

0.17

331

1579

Asthma (only as main-diagnosis)

388

1045

2.08

35.35

1.7

1.5

3.26

3.46

mg/l

0.61

369

1008

Malignant neoplasm of digestive organs, including Hilmo

191

505

2.79

35.28

1.6

1.5

4.14

3.77

mg/l

0.56

183

481

Hypertension, essential

503

1508

1.89

35.24

1.8

4.47

3.03

mg/l

8.21

488

1452

Glomerular disorders in diseases classified elsewhere

128

384

3.39

35.14

2.2

1.7

10.14

4.01

mg/l

7.81

121

372

L04AA Selective immunosuppressants

194

755

2.60

33.28

1.8

1.9

5.16

3.70

mg/l

2.61

183

729

Disorders of lacrimal system

350

1717

2.02

33.02

1.9

1.8

3.59

3.89

mg/l

0.71

336

1645

Other soft tissue disorders, not elsewhere classified

612

2004

1.74

33.01

1.8

1.9

3.56

3.87

mg/l

0.91

586

1920

Zoster [herpes zoster], including avohilmo

402

2033

1.92

32.71

1.9

1.8

3.66

3.96

mg/l

0.94

385

1945

Syncope and collapse

279

1061

2.21

32.29

1.7

1.8

4.08

3.82

mg/l

0.39

264

1011

Erysipelas, including avohilmo

455

1818

1.86

32.24

1.8

1.7

4.53

3.41

mg/l

4.05

432

1745

Malignant neoplasm of digestive organs

171

472

2.78

31.77

1.6

1.5

4.08

3.83

mg/l

0.34

163

450

Other and unspecified dermatitis

390

2066

1.90

30.93

1.8

3.97

3.68

mg/l

0.62

371

1982

Other bacterial intestinal infections, including avohilmo

200

819

2.47

30.84

2.7

1.7

4.68

3.88

mg/l

1.09

186

784

Hypertension

492

1527

1.82

30.82

1.8

4.53

3.01

mg/l

8.29

476

1468

Hypertensive diseases

492

1528

1.82

30.78

1.8

4.53

3.01

mg/l

8.29

476

1469

malignant neoplasm of male genital organs, including Hilmo

129

230

3.39

30.76

1.5

1.3

4.06

4.25

mg/l

0.16

121

222

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

261

726

2.28

30.52

2.0

1.7

3.70

2.76

mg/l

2.71

251

695

Non-ischemic cardiomyopathy

267

968

2.21

30.46

2.0

1.8

4.83

3.83

mg/l

3.81

258

930

Dermatitis

450

2450

1.81

30.31

1.9

1.8

3.97

3.70

mg/l

0.64

427

2353

Other interstitial pulmonary diseases

157

577

2.76

30.30

1.7

1.8

4.28

4.57

mg/l

0.31

148

553

Interstitial lung disease endpoints

157

577

2.76

30.30

1.7

1.8

4.28

4.57

mg/l

0.30

148

551

Interstitial lung disease

157

577

2.76

30.30

1.7

1.8

4.28

4.57

mg/l

0.30

148

551

Implicit fungal Sepsis, including avohilmo

201

4.16

30.28

2.0

1.7

6.85

3.49

mg/l

2.09

195

ILD, hospital admissions

156

572

2.77

30.24

1.7

1.8

4.29

4.57

mg/l

0.30

147

546

Spondylopathies

531

1788

1.76

30.09

1.9

1.8

3.75

3.87

mg/l

0.24

508

1709

Other diseases of intestines

654

2190

1.67

30.08

1.9

1.8

4.09

3.57

mg/l

1.89

617

2104

Pain in limb

543

1991

1.74

29.85

1.8

1.9

3.64

3.87

mg/l

0.56

525

1909

Symptoms and signs involving the circulatory and respiratory systems

588

1714

1.72

29.73

1.8

3.70

3.69

mg/l

0.03

562

1644

Bacterial pneumonia, not elsewhere classified

272

1121

2.14

29.61

3.2

1.5

4.16

3.68

mg/l

1.15

262

1074

Other and unspecified polyneuropathies, also in other diseases

181

722

2.54

29.60

1.9

1.7

3.97

4.49

mg/l

0.71

175

684

Diseases of the musculoskeletal system and connective tissue

284

643

2.22

29.55

2.1

1.6

4.06

3.83

mg/l

0.31

277

609

Other viral diseases

202

845

2.40

29.44

2.6

1.8

3.93

3.62

mg/l

0.48

196

810

Diseases of the skin and subcutaneous tissue

606

1791

1.70

29.34

1.9

1.8

3.95

3.79

mg/l

0.32

585

1709

Osteoporosis

223

895

2.31

29.26

2.0

1.7

3.95

4.23

mg/l

0.42

211

850

Diarrhoea and gastroenteritis of presumed infectious origin

455

2292

1.78

28.85

2.0

1.7

4.40

3.63

mg/l

2.36

432

2195

Other respiratory diseases principally affecting the interstitium

173

687

2.55

28.58

1.8

1.7

4.53

4.64

mg/l

0.10

162

656

Lower back pain or/and sciatica

690

2679

1.61

27.99

1.9

1.8

3.58

3.85

mg/l

0.89

658

2573

Other specified/unspecified arthritis

209

913

2.31

27.89

2.2

1.8

4.01

3.77

mg/l

0.30

199

876

malignant neoplasm of male genital organs

122

225

3.28

27.84

1.4

1.3

4.04

4.27

mg/l

0.20

115

218

Heart failure and bmi 25plus

271

849

2.15

27.81

1.8

1.9

4.81

4.27

mg/l

1.04

258

818

Other diseases of pleura

354

1631

1.90

27.44

1.8

4.81

4.13

mg/l

1.62

341

1555

Pain in throat and chest

498

1698

1.74

27.19

2.0

1.8

3.48

3.71

mg/l

0.60

476

1628

Disorders of eyelid, lacrimal system and orbit

582

2603

1.64

26.80

1.9

1.8

3.62

3.88

mg/l

0.81

560

2496

Glomerulonephritis

100

306

3.32

26.71

2.2

1.8

7.96

4.24

mg/l

4.50

299

Codeine or tramadol medication

698

2391

1.59

26.49

1.8

3.75

3.83

mg/l

0.19

666

2292

Erysipelas

353

1636

1.87

26.15

1.8

1.6

4.66

3.50

mg/l

3.32

335

1566

Other/unspecified dorsalgia

264

1281

2.05

26.10

1.9

1.7

3.57

3.83

mg/l

0.50

257

1217

Non-rheumatic valve diseases

328

1215

1.94

26.07

1.9

4.32

3.67

mg/l

1.87

320

1159

Valvular heart disease excluding rheumatic fever

329

1222

1.93

26.01

1.9

4.32

3.69

mg/l

1.75

321

1166

Acute sinusitis

327

1569

1.90

25.88

2.4

1.7

3.74

3.49

mg/l

0.46

309

1510

Other special examinations and investigations of persons without complaint or reported diagnosis

388

1053

1.87

25.84

2.0

1.7

4.23

3.76

mg/l

1.01

372

999

Malignant neoplasm of prostate, including Hilmo

119

222

3.18

25.73

1.5

1.3

4.17

4.32

mg/l

0.11

111

215

Gastrointestinal diseases

311

773

2.02

25.71

2.0

1.6

4.10

3.12

mg/l

2.95

302

738

Intestinal infectious diseases, including avohilmo, including avohilmo

723

2583

1.56

25.68

2.1

1.7

4.20

3.68

mg/l

1.85

689

2478

Other viral diseases, including avohilmo

237

1118

2.11

25.47

2.4

1.8

3.74

3.47

mg/l

0.47

228

1071

Other dorsopathies, not elsewhere classified

599

1904

1.64

25.44

1.8

1.7

3.56

3.80

mg/l

0.73

570

1818

Pulmonary heart disease, diseases of pulmonary circulation

256

1262

2.04

25.20

2.2

1.7

4.39

4.23

mg/l

0.21

245

1202

Myeloproliferative diseases

283

3.35

25.13

1.4

1.8

3.13

4.46

mg/l

4.60

277

ILD, hospital admission 2, with pulmonary infections

268

3.41

25.10

1.7

1.5

4.54

3.92

mg/l

0.53

258

Diseases of oesophagus, stomach and duodenum

662

2479

1.58

25.02

1.8

4.03

3.65

mg/l

1.23

635

2373

Pain (limb, back, neck, head abdominally)

428

1207

1.78

24.37

1.7

1.8

4.30

3.95

mg/l

0.63

413

1153

Malignant neoplasm of prostate

115

219

3.12

24.24

1.4

1.3

4.08

4.34

mg/l

0.22

107

212

Complications of medical and surgical care

493

2694

1.65

23.94

1.9

1.8

4.23

3.75

mg/l

1.12

476

2581

Other disorders of bone

147

594

2.50

23.47

2.5

1.7

3.66

3.84

mg/l

0.20

142

574

Pulmonary embolism

236

1162

2.05

23.37

2.3

1.7

4.24

4.21

mg/l

0.04

227

1106

Cardiac arrhythmias

353

1244

1.83

23.04

1.9

1.8

3.98

3.07

mg/l

3.50

347

1193

Pulmonary heart disease

236

1170

2.03

22.94

2.3

1.7

4.24

mg/l

0.00

227

1114

Persons with potential health hazards related to communicable diseases

214

1023

2.08

22.33

1.9

1.7

3.46

3.50

mg/l

0.05

207

979

ILD, hospital admissions 1, main diag only

132

522

2.56

22.16

1.7

1.8

4.40

4.55

mg/l

0.12

124

499

Pain in joint

348

1182

1.82

22.13

1.8

3.58

3.81

mg/l

0.40

331

1131

Fentanyl

290

3.13

22.03

2.9

1.7

4.21

4.24

mg/l

0.02

279

Colorectal cancer, including Hilmo

112

381

2.75

21.59

1.7

1.5

4.62

4.02

mg/l

0.62

107

362

Acute tubulo-interstitial nephritis

394

1957

1.71

21.53

1.9

1.8

5.04

2.97

mg/l

9.08

374

1877

Cough

270

1332

1.90

21.50

2.1

1.8

3.52

3.70

mg/l

0.38

254

1276

Diseases of salivary glands

237

1206

1.98

21.44

2.0

1.8

3.54

3.86

mg/l

0.49

228

1158

Other specific joint derangements/joint disorders

414

1518

1.70

21.35

1.8

3.39

3.69

mg/l

0.72

392

1453

Diseases of pulp and periapical tissues, including avohilmo

614

2049

1.55

21.06

1.8

1.7

3.94

3.85

mg/l

0.18

588

1954

Infections of the skin and subcutaneous tissue

377

2188

1.70

20.95

2.1

1.8

4.31

3.62

mg/l

1.77

363

2094

Endocrine, nutritional and metabolic diseases

434

1296

1.70

20.94

1.9

4.24

3.04

mg/l

5.21

415

1244

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

606

2502

1.54

20.54

2.0

1.8

3.92

3.82

mg/l

0.23

582

2400

Bleeding

538

2411

1.57

20.50

1.7

1.8

4.75

3.70

mg/l

3.99

506

2319

Dermatitis and eczema

676

2674

1.50

20.35

1.8

4.03

3.75

mg/l

0.74

650

2565

Rheumatoid arthritis

224

1001

1.99

20.32

1.5

1.8

3.52

3.94

mg/l

0.97

211

957

Nutritional anaemias

346

1921

1.73

20.10

1.7

1.8

4.68

3.99

mg/l

1.61

324

1835

Colorectal cancer

101

351

2.77

19.92

1.7

1.5

4.50

4.10

mg/l

0.39

333

Nausea and vomiting

195

927

2.06

19.83

1.9

1.8

4.40

3.99

mg/l

0.55

184

886

Disorders of other endocrine glands

284

1547

1.82

19.79

1.9

1.8

5.23

3.69

mg/l

3.32

275

1478

Symptoms and signs concerning food and fluid intake

265

3.08

19.36

1.5

1.7

3.74

4.07

mg/l

0.30

254

All influenza (not pneumonia)

101

377

2.70

19.05

2.8

1.7

4.13

3.67

mg/l

0.51

365

Benign neoplasms

555

1958

1.55

18.93

1.7

1.9

3.73

3.82

mg/l

0.18

531

1880

Disorders of lipoprotein metabolism and other lipidaemias

501

1943

1.57

18.79

1.7

1.8

4.51

3.58

mg/l

3.47

482

1858

Other arrhythmias

375

1684

1.67

18.58

1.6

1.8

3.87

3.38

mg/l

1.43

364

1612

Diverticular disease of intestine

471

1853

1.59

18.51

1.9

1.8

4.43

3.74

mg/l

2.42

449

1780

Diseases of the eye and adnexa

421

1282

1.65

18.42

1.9

1.8

4.07

3.54

mg/l

1.22

405

1240

Hypothyroidism, strict autoimmune

406

1632

1.64

18.29

1.9

1.8

4.12

3.92

mg/l

0.34

387

1567

Dorsopathies

573

1907

1.53

18.12

1.9

1.7

3.73

3.80

mg/l

0.12

548

1821

Arthropathies

482

1541

1.58

18.00

1.7

1.8

4.00

3.72

mg/l

0.56

459

1474

Antihypertensive medication - note that there are other indications

291

840

1.82

17.96

1.9

1.8

4.07

2.70

mg/l

4.49

279

809

Other disorders of skin and subcutaneous tissue

473

2581

1.55

17.79

2.0

1.8

4.09

3.84

mg/l

0.48

461

2471

Persons encountering health services for examination and investigation

356

1053

1.70

17.46

1.9

1.7

4.24

3.76

mg/l

0.98

346

999

Care involving use of rehabilitation procedures

366

2017

1.64

17.43

1.9

1.8

4.20

3.28

mg/l

2.81

353

1933

Constipation

561

2546

1.50

17.24

2.1

1.8

3.96

3.80

mg/l

0.35

528

2449

Dental operations

355

1083

1.69

17.18

1.7

4.31

4.08

mg/l

0.39

341

1039

Factors influencing health status and contact with health services

151

333

2.28

17.00

1.9

1.5

4.49

3.31

mg/l

2.45

146

314

Diseases of oral cavity, salivary glands and jaws

333

1003

1.72

17.00

1.7

1.8

4.47

4.13

mg/l

0.58

319

956

Other CVD (FINNGEN)

257

2.76

16.96

2.1

1.7

4.24

3.16

mg/l

1.21

246

Other disorders of fluid, electrolyte and acid-base balance

220

1117

1.87

16.69

1.9

1.8

5.58

3.79

mg/l

4.09

206

1058

Iron deficiency anaemia

289

1661

1.71

16.63

1.7

1.8

4.85

4.07

mg/l

1.52

269

1583

Disorders of gallbladder, biliary tract and pancreas

602

2559

1.47

16.55

1.9

1.8

4.06

3.73

mg/l

0.80

574

2459

Use of hypnotics and sedatives

628

2479

1.45

16.05

2.0

1.7

3.81

3.79

mg/l

0.04

600

2385

Symptoms and signs involving the urinary system

479

2388

1.52

16.04

1.7

1.8

4.02

3.86

mg/l

0.29

451

2296

Other joint disorders

457

1541

1.55

15.74

1.7

1.8

3.39

3.72

mg/l

0.89

433

1474

Diagnoses used for exclusion with ILD

183

955

1.93

15.56

1.6

1.7

3.98

4.31

mg/l

0.52

173

912

Diseases of the digestive system

306

1848

1.65

15.33

1.9

1.7

5.15

3.95

mg/l

2.04

288

1764

Symptoms and signs involving the digestive system and abdomen

572

1953

1.47

15.30

1.8

4.05

3.79

mg/l

0.63

546

1876

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

387

2447

1.56

15.16

1.9

1.8

4.22

3.81

mg/l

0.66

371

2341

Complications of procedures, not elsewhere classified

481

2602

1.49

15.12

1.8

4.32

3.71

mg/l

1.50

464

2492

Other and unspecified iron deficiency

229

1301

1.77

14.73

1.6

1.8

5.03

4.05

mg/l

1.62

214

1242

Sleep apnoea, including avohilmo

600

2533

1.44

14.70

1.7

1.9

3.79

3.83

mg/l

0.09

571

2439

Hyperlipidaemia, other/unspecified

260

1374

1.71

14.65

1.5

1.8

4.63

3.85

mg/l

1.43

254

1310

Rheumatoid arthritis, including avohilmo

250

1463

1.72

14.60

1.5

1.9

3.43

3.96

mg/l

1.79

236

1398

Symptoms and signs involving the nervous and musculoskeletal systems

367

2362

1.56

14.57

1.8

3.67

3.89

mg/l

0.42

353

2255

Nerve, nerve root and plexus disorders

625

2650

1.42

14.40

1.8

3.68

3.86

mg/l

0.42

597

2541

Fibromyalgia

251

2.82

14.39

2.0

1.7

2.22

3.56

mg/l

6.23

244

Cerebrovascular diseases (FINNGEN)

169

604

1.97

14.37

1.8

1.7

4.35

2.88

mg/l

2.82

162

578

Haemorrhage from respiratory passages

225

1130

1.77

14.36

1.7

1.8

4.15

4.10

mg/l

0.07

220

1081

Gingivitis and periodontal diseases

571

2039

1.45

14.30

1.7

1.8

4.05

3.84

mg/l

0.44

542

1959

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

579

2595

1.43

14.28

1.9

1.7

4.14

3.68

mg/l

1.41

555

2490

Ischemic heart diseases

504

2044

1.47

14.05

1.9

4.49

3.63

mg/l

2.94

486

1972

Seropositive rheumatoid arthritis

155

788

1.97

14.03

1.5

1.7

3.70

4.04

mg/l

0.52

147

752

Abnormalities of heart beat

215

1183

1.77

13.93

1.6

1.8

3.83

3.84

mg/l

0.01

205

1132

Disorders of lens

430

1766

1.52

13.89

2.0

1.8

4.71

3.71

mg/l

3.03

409

1704

Other functional intestinal disorders

290

1620

1.63

13.81

2.0

1.7

4.35

3.70

mg/l

1.24

275

1548

Diseases of pulp and periapical tissues and dental caries

372

1214

1.58

13.78

1.8

1.7

4.31

4.04

mg/l

0.50

357

1163

Exposure to unspecified factor

584

2804

1.42

13.78

1.8

3.82

3.79

mg/l

0.05

556

2693

Periodontitis

586

2642

1.42

13.54

1.8

4.03

3.75

mg/l

0.73

555

2545

Other skin changes

148

758

1.97

13.39

2.8

1.8

3.79

4.38

mg/l

0.87

141

724

Urticaria and erythema

218

1259

1.74

13.38

1.9

1.8

3.47

3.67

mg/l

0.29

209

1206

Persons encountering health services in other circumstances, wide

651

2401

1.40

13.31

1.7

1.9

4.26

3.71

mg/l

1.95

625

2295

DVT of lower extremities

137

685

2.02

13.28

2.8

1.8

3.67

4.21

mg/l

1.09

132

657

Gonarthrosis [arthrosis of knee](FG)

409

1560

1.51

12.98

1.9

1.8

3.80

3.83

mg/l

0.05

392

1498

Chronic periodontitis, including avohilmo

581

2648

1.40

12.74

1.8

4.06

3.74

mg/l

0.84

551

2550

Genitourinary diseases

287

877

1.65

12.66

1.9

1.8

4.93

2.80

mg/l

8.33

281

836

General examination and investigation of persons without complaint and reported diagnosis

322

1051

1.59

12.64

1.7

4.23

3.76

mg/l

0.72

308

997

Pure hypercholesterolaemia

437

1885

1.48

12.58

1.7

1.8

4.63

3.63

mg/l

3.46

421

1800

Mycoses

187

1057

1.78

12.44

2.5

1.8

4.55

3.96

mg/l

0.52

178

1008

Heart failure and coronary heart disease

297

1308

1.60

12.44

1.7

1.8

5.31

4.17

mg/l

3.10

278

1254

Benign neoplasm of colon, rectum, anus and anal canal

415

2389

1.47

12.41

1.7

1.9

3.89

4.04

mg/l

0.31

397

2292

Unspecified acute lower respiratory infection

103

475

2.18

12.39

2.5

1.7

3.94

4.07

mg/l

0.12

456

Spondylosis

331

1677

1.55

12.36

1.7

1.8

3.80

3.88

mg/l

0.11

318

1603

Caries of dentine, including avohilmo

449

1560

1.47

12.35

1.9

1.7

4.23

4.00

mg/l

0.42

432

1500

Sleep apnoea

563

2539

1.40

12.24

1.7

1.9

3.82

3.84

mg/l

0.04

536

2447

Senile cataract

401

1637

1.49

12.17

1.9

1.8

4.55

3.81

mg/l

1.79

380

1579

Other noninfective gastroenteritis and colitis

160

869

1.85

12.12

1.8

1.9

4.12

3.93

mg/l

0.19

150

833

Symptoms and signs involving cognition, perception, emotional state and behaviour

554

2651

1.40

12.10

1.7

1.8

3.65

3.75

mg/l

0.23

520

2554

Abdominal and pelvic pain

549

1953

1.41

12.08

1.8

3.93

3.79

mg/l

0.32

525

1876

Dental caries, including avohilmo

416

1434

1.49

12.01

1.8

1.7

4.23

3.98

mg/l

0.48

399

1380

Undetermined asthma, excluding more controls

294

2.50

11.95

1.4

1.5

3.54

3.32

mg/l

0.18

285

Other reaction to severe stress, and adjustment disorders

193

1115

1.74

11.86

1.9

1.8

3.82

3.43

mg/l

0.49

185

1074

Noninfectious colitis NAS

433

2.21

11.79

1.6

1.8

4.04

4.21

mg/l

0.12

422

Asthma, hospital admission 2, infections

345

2241

1.50

11.75

1.9

1.8

4.06

3.89

mg/l

0.27

326

2140

Asthma-related infections

345

2241

1.50

11.75

1.9

1.8

4.06

3.89

mg/l

0.27

326

2140

Herpesviral [herpes simplex] infections, including avohilmo

150

808

1.87

11.71

2.0

1.8

3.42

3.59

mg/l

0.27

142

776

Hard cardiovascular diseases

488

2026

1.43

11.66

1.9

1.8

4.37

3.68

mg/l

2.18

472

1952

Percutaneous Coronary Intervention

469

2002

1.43

11.35

1.9

4.56

3.66

mg/l

3.06

452

1930

Persons encountering health services in other circumstances

243

1495

1.61

11.32

1.8

1.9

3.43

3.62

mg/l

0.41

231

1426

Disorders of the thyroid gland

537

2510

1.39

11.29

1.9

1.8

4.02

3.77

mg/l

0.60

515

2407

Hernia

526

2515

1.39

11.21

1.7

1.8

4.25

3.68

mg/l

1.84

505

2412

Colorectal adenocarcinoma

299

2.42

11.21

1.7

1.5

4.57

4.28

mg/l

0.20

285

Vocal cord dysfunction

286

2.38

11.15

2.0

1.8

4.49

3.36

mg/l

0.77

279

Undetermined asthma

305

2.41

11.08

1.4

1.5

3.54

3.59

mg/l

0.04

294

Presence of other functional implants

370

1717

1.48

11.02

1.9

1.7

4.12

3.96

mg/l

0.22

349

1649

Diseases of arteries, arterioles and capillaries

419

2138

1.44

11.01

1.7

1.8

4.93

3.86

mg/l

3.32

407

2043

Coronary revascularization (ANGIO or CABG)

467

2002

1.42

10.98

1.9

4.57

3.66

mg/l

3.13

451

1930

AV-block

116

498

2.00

10.85

1.5

1.8

4.67

4.11

mg/l

0.71

109

467

Other diseases of hard tissues of teeth

300

998

1.56

10.85

1.6

1.8

4.29

4.13

mg/l

0.21

286

952

253

1593

1.58

10.84

2.1

1.9

3.84

3.73

mg/l

0.14

238

1524

Fracture of lumbar spine and pelvis

151

834

1.82

10.83

1.6

1.8

4.79

4.35

mg/l

0.45

144

793

Disturbances of skin sensation

163

928

1.77

10.65

1.5

1.8

3.08

3.80

mg/l

1.85

155

891

Disorders of parathyroid gland

138

741

1.85

10.53

1.7

1.8

7.10

4.17

mg/l

3.64

131

709

Sulfasalazine

155

877

1.78

10.36

1.4

1.8

3.38

3.76

mg/l

0.63

146

846

Sciatica+with lumbago

293

1715

1.52

10.30

1.8

1.7

3.43

3.74

mg/l

0.80

282

1638

Asthma-related pneumonia

227

1420

1.60

10.25

2.1

1.8

4.38

4.24

mg/l

0.17

216

1353

Gout, unspecified

140

773

1.82

10.19

1.7

5.86

4.34

mg/l

2.49

133

732

Other diseases of urinary system

552

2274

1.36

10.18

1.8

3.85

3.73

mg/l

0.27

524

2183

Phlebitis and thrombophlebitis (not including DVT)

148

831

1.79

10.18

2.6

1.8

4.04

3.99

mg/l

0.04

138

797

Asthma-related pneumonia or sepsis

227

1423

1.60

10.16

2.1

1.8

4.38

4.23

mg/l

0.18

216

1356

Asthma, hospital admissions 3, pneumonia

227

1423

1.60

10.16

2.1

1.8

4.38

4.23

mg/l

0.18

216

1356

Weight loss

344

2.26

10.12

1.5

1.8

3.72

4.36

mg/l

0.69

332

Cholelithiasis, broad definition with cholecystitis

502

2436

1.37

9.96

1.9

1.8

3.84

3.77

mg/l

0.13

476

2343

Disorders of sclera, cornea, iris and ciliary body

315

2139

1.48

9.93

1.9

1.8

3.55

3.75

mg/l

0.36

300

2048

Type 2 diabetes, wide definition

468

2128

1.39

9.85

1.7

1.8

4.87

3.55

mg/l

5.58

446

2047

Candidiasis

466

2.05

9.84

2.5

1.8

5.57

3.95

mg/l

0.88

451

Soft tissue disorders

535

2009

1.37

9.77

1.7

1.9

3.89

3.88

mg/l

0.02

512

1923

Urticaria

165

967

1.71

9.77

1.9

1.8

3.43

3.61

mg/l

0.20

160

926

Hypothyroidism, other/unspecified

488

2338

1.37

9.70

1.9

1.8

4.01

3.75

mg/l

0.56

468

2238

Other disorders of urethra and urinary system

401

1972

1.42

9.65

1.8

4.28

3.78

mg/l

0.96

385

1889

Other symptoms and signs involving the nervous and musculoskeletal systems

245

1590

1.55

9.60

1.8

3.45

3.83

mg/l

0.65

237

1518

Intracranial trauma

299

1352

1.50

9.51

2.1

1.8

3.82

3.84

mg/l

0.02

285

1297

Persons encountering health services for other counselling and medical advice, not elsewhere classified

601

2397

1.33

9.50

1.6

1.9

4.27

3.71

mg/l

1.98

584

2293

Conduction disorders

176

840

1.69

9.48

1.4

1.8

4.38

3.82

mg/l

1.07

164

797

GI-bleeding

202

1258

1.61

9.47

1.9

1.7

5.68

4.24

mg/l

1.64

189

1199

Other intervertebral disc disorders

434

1852

1.40

9.47

1.8

1.7

3.58

3.83

mg/l

0.66

417

1770

Emergency coronary revascularization (for ACS)

500

2214

1.37

9.44

1.8

4.55

3.81

mg/l

2.41

483

2123

Other gastritis (incl. Duodenitis)

145

831

1.75

9.34

1.8

5.29

4.10

mg/l

1.46

138

791

Other or unspecified ileus, impaction or obstruction

123

672

1.84

9.29

2.0

1.7

5.01

4.03

mg/l

1.22

115

646

Gout, idiopatic and unspecified

172

1035

1.67

9.29

1.6

1.7

5.61

4.31

mg/l

2.53

165

984

Conjunctivitis (acute, non atopic)

164

972

1.69

9.20

2.6

1.8

3.98

3.63

mg/l

0.36

152

932

Neurological diseases

434

1559

1.40

9.20

1.9

1.8

3.76

3.88

mg/l

0.19

420

1493

Missing teeth due to accident, extraction or parodontitis

382

2431

1.41

9.17

2.2

1.8

4.25

3.87

mg/l

0.75

367

2336

Hypo-osmolality and hyponatraemia

111

585

1.89

9.16

1.9

1.8

4.60

3.96

mg/l

0.77

102

556

Hypothyreosis and Thyroxine purchase for inclusion criteria

504

2442

1.35

9.15

1.9

1.8

3.99

3.76

mg/l

0.47

482

2336

Noninfective enteritis and colitis

259

1718

1.51

9.14

1.8

3.98

3.76

mg/l

0.32

243

1640

Hyperparathyroidism

119

640

1.85

9.13

1.7

1.8

7.51

4.23

mg/l

3.46

112

614

Methotrexate

406

2.08

9.09

1.9

3.42

3.80

mg/l

0.54

394

Non-invasive ventilation

140

687

1.77

9.05

2.7

1.7

4.01

3.27

mg/l

0.80

128

663

Cholelithiasis

478

2402

1.36

9.02

1.9

1.8

3.72

3.78

mg/l

0.13

454

2310

Asthma (diagnoses ohter than nonallergic)

478

2855

1.35

8.99

1.7

1.8

3.61

3.81

mg/l

0.48

459

2735

Major coronary heart disease event

488

2150

1.36

8.99

1.8

4.62

3.73

mg/l

2.98

470

2068

Hypertensive heart and/or renal disease

168

734

1.68

8.81

1.8

5.44

3.53

mg/l

5.49

160

700

Non-allergic asthma (mode), excluding more controls

427

2.03

8.79

1.9

1.5

3.55

3.41

mg/l

0.18

413

Pain in thoracic spine

480

1.97

8.76

1.7

1.8

3.56

3.92

mg/l

0.45

459

Diseases of the ear and mastoid process

601

2287

1.32

8.73

1.9

1.8

3.81

3.71

mg/l

0.20

571

2199

Kela reimbursement Agammaglobulinemia (D80-84)

8.59

8.69

3.7

1.6

4.09

4.47

mg/l

0.11

Chronic lower respiratory diseases

642

2597

1.30

8.66

1.7

1.9

3.63

3.79

mg/l

0.43

615

2492

Paracetamol or NSAID medication

170

2.26

8.66

1.6

1.5

3.91

4.10

mg/l

0.11

164

Other CVD

135

776

1.75

8.65

2.0

1.7

4.60

4.79

mg/l

0.14

126

734

Abnormality of white blood cells, not elsewhere classified

7.02

8.49

1.2

1.4

3.41

2.68

mg/l

1.01

Paralytic ileus and intestinal obstruction

162

983

1.65

8.47

2.1

1.7

4.97

4.03

mg/l

1.33

153

937

Other disorders of ear

515

2502

1.33

8.43

1.9

1.8

3.89

3.81

mg/l

0.16

491

2405

Arthrosis

369

1434

1.41

8.42

1.8

4.08

3.82

mg/l

0.46

354

1372

Disease of hard tissues of teeth, NOS

279

981

1.49

8.38

1.7

1.8

3.43

4.08

mg/l

2.61

271

938

N06DA Anticholinesterases

1234

0.52

8.38

1.8

1.7

4.05

4.68

mg/l

0.68

1163

Use of anticholinesterases

1234

0.52

8.38

1.8

1.7

4.05

4.68

mg/l

0.68

1163

Other viral diseases, not elsewhere classified, including avohilmo

134

771

1.73

8.36

2.5

1.8

3.27

3.60

mg/l

0.50

127

743

Hypersplenism

15.56

8.36

1.5

1.7

3.94

4.60

mg/l

—

Dizziness and giddiness

431

2468

1.36

8.35

1.6

1.8

3.81

3.79

mg/l

0.03

404

2379

414

2.02

8.29

1.7

2.0

3.67

3.44

mg/l

0.23

401

Other diseases of the digestive system

196

1256

1.57

8.22

1.9

1.7

5.78

4.21

mg/l

1.79

182

1198

Chronic myeloid leukaemia

18.21

8.19

1.2

1.7

2.54

2.83

mg/l

—

Meniscus derangement

296

1355

1.45

8.17

1.9

1.8

3.30

3.87

mg/l

2.44

287

1299

Injuries to the abdomen, lower back, lumbar spine and pelvis

234

1538

1.50

8.15

1.7

4.23

4.02

mg/l

0.27

225

1464

262

1608

1.47

8.06

1.9

1.8

4.05

4.35

mg/l

0.65

243

1537

Diseases of liver

210

1378

1.53

7.94

1.8

4.12

3.83

mg/l

0.41

199

1321

Actinic keratosis

246

1514

1.48

7.92

1.8

4.02

4.43

mg/l

0.98

230

1444

Skin changes due to chronic exposure to nonionizing radiation

250

1540

1.47

7.82

1.8

4.04

4.40

mg/l

0.82

233

1469

Benign neoplasm: Colon

337

2274

1.39

7.82

1.7

1.9

3.83

4.12

mg/l

0.77

322

2183

Dysphagia

157

967

1.63

7.81

1.8

3.51

4.11

mg/l

1.46

151

926

Coeliac disease

369

2.05

7.81

2.1

1.8

4.04

3.88

mg/l

0.09

360

Conductive and sensorineural hearing loss

458

2289

1.33

7.53

1.7

1.8

3.91

3.93

mg/l

0.03

437

2199

Gonarthrosis

339

1369

1.40

7.51

1.9

1.8

3.80

3.84

mg/l

0.06

324

1312

Other diseases of lip and oral mucosa

247

1696

1.46

7.51

1.8

3.63

3.75

mg/l

0.18

238

1622

Candidiasis, including avohilmo

171

1090

1.57

7.40

2.1

1.8

4.66

3.73

mg/l

0.83

160

1043

Hypothyroidism, strict autoimmune, 3 medication purchases required

448

2267

1.33

7.37

1.8

4.16

3.72

mg/l

1.17

427

2168

Ischaemic heart disease, wide definition

448

2075

1.33

7.32

1.7

1.8

4.41

3.69

mg/l

2.17

428

2001

Disorders of conjunctiva

434

2532

1.33

7.30

2.0

1.8

3.72

3.62

mg/l

0.16

407

2438

Coxarthrosis [arthrosis of hip](FG)

294

1431

1.42

7.19

1.6

1.8

3.78

3.94

mg/l

0.31

280

1372

Other inflammation of eyelid, including avohilmo

225

1532

1.47

7.15

2.1

1.8

3.15

3.67

mg/l

1.63

219

1472

Non-allergic asthma (mode)

461

1.88

7.13

1.9

1.5

3.55

3.67

mg/l

0.14

447

Episodal and paroxysmal disorders

562

2211

1.29

7.11

1.8

3.74

3.79

mg/l

0.09

539

2119

Hypotension

115

672

1.72

7.05

2.0

1.7

4.43

4.71

mg/l

0.23

106

635

Intestinal stricture

188

1245

1.52

6.89

2.0

1.7

5.02

4.27

mg/l

0.99

177

1190

Disorders of choroid and retina

462

2476

1.31

6.85

1.7

1.8

4.84

3.78

mg/l

2.77

436

2378

Benzodiazepine use

536

2826

1.28

6.77

1.8

3.53

3.84

mg/l

1.06

499

2725

Iridocyclitis

131

804

1.64

6.69

1.8

3.32

3.98

mg/l

1.35

126

772

Iron deficiency anaemia secondary to blood loss (chronic)

564

1.77

6.66

1.7

1.8

4.70

4.33

mg/l

0.29

541

Coronary atherosclerosis

371

1740

1.35

6.65

1.8

1.9

4.40

3.83

mg/l

1.33

355

1677

Mental and behavioural disorders due to alcohol, excluding acute intoxication

109

1792

0.60

6.62

1.3

1.8

4.46

3.88

mg/l

0.49

101

1726

Chronic periodontitis, complicated

331

2383

1.36

6.61

1.7

1.8

4.38

3.76

mg/l

1.30

313

2295

Sleep disorders (combined)

585

2408

1.27

6.61

1.7

1.8

3.76

3.86

mg/l

0.20

555

2315

Other antidepressants

550

2198

1.28

6.53

1.8

3.46

3.96

mg/l

2.01

520

2120

Benign neoplasm of mouth and pharynx

374

1.94

6.52

1.4

1.8

3.82

4.33

mg/l

0.58

363

Calcific aortic valvular stenosis, including rheumatic fever

180

1149

1.51

6.50

1.9

1.8

4.94

4.59

mg/l

0.42

173

1086

Gastro-oesophageal reflux disease

371

2352

1.33

6.48

1.7

1.8

3.85

3.69

mg/l

0.29

356

2254

Primary hyperparathyroidism

382

1.93

6.47

1.8

1.9

4.21

4.19

mg/l

0.01

368

Unspecified haematuria

255

1470

1.42

6.45

1.7

1.8

4.83

4.15

mg/l

0.86

240

1410

Calcific aortic valvular stenosis, diagnosis (helper)

179

1147

1.51

6.39

1.9

1.8

4.91

4.60

mg/l

0.36

172

1084

Operations 2 for CAVS

179

1147

1.51

6.39

1.9

1.8

4.91

4.60

mg/l

0.36

172

1084

Alcohol use disorder, ICD-based

1665

0.59

6.38

1.4

1.8

4.65

3.85

mg/l

0.67

1604

Calcific aortic valvular stenosis, operated

179

1148

1.51

6.37

1.9

1.8

4.91

4.59

mg/l

0.36

172

1085

Calcific aortic valvular stenosis

179

1148

1.51

6.37

1.9

1.8

4.91

4.59

mg/l

0.36

172

1085

STROKE

307

1506

1.38

6.35

1.7

1.8

4.09

3.55

mg/l

1.21

295

1456

Cystitis

450

2057

1.30

6.35

1.9

1.8

3.77

3.79

mg/l

0.03

430

1973

Alcohol use disorder, Swedish definition

149

2073

0.65

6.35

1.5

1.8

4.62

3.89

mg/l

0.83

140

1985

Malignant neoplasm of pancreas, including Hilmo

2.90

6.30

1.7

1.4

3.54

4.22

mg/l

0.58

Other arthrosis

278

1337

1.40

6.30

1.8

3.95

3.84

mg/l

0.14

267

1282

Diaphragmatic hernia

214

1484

1.45

6.27

1.7

1.8

5.03

3.95

mg/l

1.68

208

1416

Disorders of vitreous body

305

2137

1.36

6.23

1.9

1.8

4.22

3.85

mg/l

0.64

290

2053

Conjunctivitis (acute, non atopic), including avohilmo

532

2530

1.27

6.23

2.0

1.8

3.80

3.74

mg/l

0.10

505

2434

Degenerative diseases of the nervous system

1194

0.59

6.20

1.5

1.7

4.29

4.75

mg/l

0.62

1135

Angina pectoris

329

1615

1.35

6.19

1.9

4.34

3.89

mg/l

0.91

311

1557

Disorders of vitreous body and globe

311

2178

1.35

6.13

1.9

1.8

4.19

3.87

mg/l

0.54

296

2094

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

152

989

1.54

6.11

1.5

1.8

3.73

4.08

mg/l

0.57

144

947

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

322

2397

1.34

6.08

1.9

1.8

4.50

3.84

mg/l

1.09

310

2295

Myalgia

131

825

1.59

6.06

1.7

1.8

3.02

3.69

mg/l

1.88

122

796

Seropositive rheumatoid arthritis, wide

155

1015

1.53

6.05

1.5

1.8

3.70

4.06

mg/l

0.59

147

973

Urinary track infection

273

977

1.40

6.03

1.9

1.8

3.55

3.06

mg/l

1.28

263

937

Collagenous colitis

301

2.01

6.03

2.1

1.8

4.44

4.18

mg/l

0.15

293

In situ neoplasms

230

1631

1.41

5.98

1.8

4.18

4.06

mg/l

0.15

217

1555

Disorders of skin appendages

250

1788

1.39

5.98

1.9

1.8

4.16

3.58

mg/l

0.89

241

1709

Concussion

244

1346

1.41

5.98

2.1

1.8

3.63

3.85

mg/l

0.41

232

1291

Obesity related asthma

195

1342

1.46

5.97

1.7

1.8

4.00

3.81

mg/l

0.27

181

1287

Necrosis of pulp, including avohilmo

298

2182

1.35

5.90

1.9

1.8

3.59

3.55

mg/l

0.04

286

2102

Mental and behavioural disorders due to alcohol

136

1986

0.65

5.89

1.3

1.8

4.54

3.86

mg/l

0.77

127

1905

Sensorineural hearing loss

430

2221

1.29

5.87

1.7

1.8

3.86

3.95

mg/l

0.17

410

2132

Temporomandibular joint disorders, including avohilmo

212

1439

1.43

5.85

2.0

1.8

2.76

3.53

mg/l

4.43

196

1387

Conjunctivitis

379

2335

1.31

5.83

2.1

1.8

3.67

3.58

mg/l

0.14

356

2249

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

11.37

5.82

2.1

1.3

3.24

4.46

mg/l

—

Asthma, including avohilmo

614

2728

1.24

5.78

1.7

1.8

3.56

3.85

mg/l

0.96

586

2616

174

2203

0.69

5.77

1.4

1.8

4.65

3.86

mg/l

1.11

164

2109

Other diseases of upper respiratory tract

575

2399

1.25

5.74

1.9

1.8

3.69

3.89

mg/l

0.58

550

2299

Ovarian cyst

160

599

1.53

5.71

1.9

1.8

3.03

3.63

mg/l

1.77

152

581

Other/unspecified seropositive rheumatoid arthritis

152

1006

1.52

5.68

1.5

1.8

3.73

4.07

mg/l

0.55

144

964

Keratitis

192

1334

1.44

5.62

2.0

1.8

3.70

3.84

mg/l

0.17

182

1277

Follow-up examination after treatment for conditions other than malignant neoplasms

199

916

1.45

5.61

2.0

1.7

4.02

3.79

mg/l

0.29

189

869

Seropositive rheumatoid arthritis, strict definition

542

1.71

5.58

1.5

1.8

3.89

4.10

mg/l

0.19

526

Alzheimer disease, including avohilmo

107

1184

0.62

5.52

1.5

1.7

4.34

4.73

mg/l

0.56

1121

Any dementia

119

1282

0.64

5.48

1.6

1.7

4.21

4.62

mg/l

0.64

108

1216

166

2152

0.69

5.46

1.4

1.8

4.73

3.87

mg/l

1.19

157

2060

Unspecific neurodegenerative disorder

133

1383

0.66

5.42

1.7

1.8

4.30

4.53

mg/l

0.24

121

1316

Dermatopolymyositis, unspecified

8.25

5.42

1.9

1.4

2.48

4.08

mg/l

0.81

Alzheimer disease

1047

0.60

5.41

1.5

1.7

4.36

4.81

mg/l

0.57

991

Other symptoms and signs involving the digestive system and abdomen

571

1.67

5.36

1.8

1.6

3.41

3.80

mg/l

0.38

549

308

0.26

5.34

1.4

1.6

8.20

4.73

mg/l

—

293

Dementia

142

1449

0.67

5.32

1.7

1.8

3.96

4.48

mg/l

0.83

129

1383

Any dementia, excluding more controls

112

1205

0.64

5.31

1.6

1.8

4.05

4.55

mg/l

0.89

102

1147

Other disorders of bladder

439

1.76

5.27

1.6

1.7

3.99

4.49

mg/l

0.46

419

Chronic sinusitis

224

1617

1.39

5.26

1.9

1.8

3.26

3.70

mg/l

1.21

211

1551

Substance abuse

166

2218

0.69

5.23

1.4

1.8

4.80

3.81

mg/l

1.30

156

2118

Acute pharyngitis

357

1.84

5.18

2.3

1.8

2.57

3.36

mg/l

2.74

348

Retention of urine

203

1167

1.41

5.12

1.6

1.8

4.76

4.24

mg/l

0.49

192

1121

Spinal stenosis

280

1542

1.34

5.11

1.9

1.7

4.09

4.03

mg/l

0.07

269

1470

Other and unspecified local infections of skin and subcutaneous tissue

313

1.90

5.10

3.5

1.8

5.34

4.14

mg/l

0.71

304

Dementia, including avohilmo

155

1538

0.68

5.10

1.7

1.8

3.90

4.49

mg/l

1.14

143

1466

Diabetic nephropathy, excluding more controls

388

1.73

5.09

1.9

1.7

10.40

3.80

mg/l

5.14

370

Chronic ulcer of skin, not elsewhere classified

217

2.09

5.09

2.2

1.6

7.31

4.73

mg/l

1.24

210

Sequelae of external causes of morbidity and mortality

148

1005

1.48

4.95

2.1

1.8

4.15

4.08

mg/l

0.06

143

961

Other diseases of anus and rectum

167

1156

1.44

4.94

2.1

1.7

3.98

3.94

mg/l

0.04

157

1103

Exclusions for E4_PCOS_CONSORTIUM

327

1563

1.31

4.91

1.7

1.8

3.50

3.54

mg/l

0.05

309

1508

Injuries to the thorax

257

1920

1.34

4.91

1.9

1.7

4.25

3.94

mg/l

0.46

241

1837

Hypertensive Heart Disease

139

702

1.51

4.90

1.8

4.99

3.56

mg/l

3.52

132

671

Other leukaemias of specified cell type

9.81

4.90

1.9

3.18

3.97

mg/l

—

Functional dyspepsia

144

977

1.48

4.84

1.9

1.8

3.55

3.88

mg/l

0.36

139

936

Visual disturbances

261

1961

1.33

4.83

1.9

1.8

4.16

3.79

mg/l

0.57

251

1874

Alcohol dependence

1050

0.56

4.83

1.4

1.8

4.79

3.91

mg/l

0.56

1011

Asthma, hospital admissions , main diagnosis only

410

2837

1.26

4.79

1.7

1.8

3.34

3.83

mg/l

2.71

388

2722

Pacemaker

210

1418

1.38

4.79

1.4

1.8

4.49

4.43

mg/l

0.08

201

1347

Injuries to the head

572

2784

1.22

4.75

2.0

1.8

3.89

3.77

mg/l

0.29

545

2673

Visual disturbances and blindness

281

2140

1.31

4.70

1.9

1.8

4.21

3.78

mg/l

0.74

266

2046

Coxibs

134

462

1.52

4.69

1.6

1.8

3.83

5.04

mg/l

2.04

128

441

Haemorrhoids and perianal venous thrombosis

187

1331

1.40

4.67

1.8

1.7

4.48

3.85

mg/l

0.59

182

1272

Vitreous haemorrhage

352

1.80

4.67

1.7

6.94

4.59

mg/l

1.40

340

Other local infections of skin and subcutaneous tissue

332

1.82

4.59

3.5

1.7

5.34

4.22

mg/l

0.66

323

Gastric ulcer

101

643

1.58

4.59

2.0

1.8

4.45

4.48

mg/l

0.02

607

Coxarthrosis

263

1277

1.33

4.54

1.6

1.8

3.78

3.91

mg/l

0.23

249

1221

Dermatopolymyositis (FG)

4.25

4.54

2.1

1.7

2.64

3.47

mg/l

0.56

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

269

1977

1.31

4.50

2.0

1.8

3.77

3.75

mg/l

0.02

253

1898

Volume depletion

291

1.87

4.50

1.7

1.8

6.47

4.01

mg/l

1.92

276

Convulsions, not elsewhere classified

538

1.62

4.48

1.4

1.8

4.54

3.67

mg/l

0.79

518

Obesity due to excess calories

237

1778

1.34

4.47

1.6

1.8

4.40

3.47

mg/l

2.18

226

1709

Other disorders of veins

218

1590

1.35

4.45

1.6

1.8

3.61

3.78

mg/l

0.36

210

1522

Idiopathic gout

329

1.81

4.42

1.5

1.7

5.58

4.43

mg/l

0.79

316

Other diseases of liver

102

657

1.56

4.42

1.8

1.9

3.71

3.96

mg/l

0.21

636

Mental and behavioural disorders due to psychoactive substance use

178

2245

0.72

4.41

1.4

1.8

4.72

3.80

mg/l

1.28

168

2145

Other (seronegative) rheumatoid arthritis, wide

107

698

1.54

4.39

1.5

1.8

3.54

4.08

mg/l

1.17

101

671

Gastroduodenal ulcer

143

988

1.45

4.35

1.8

5.25

4.37

mg/l

0.99

136

932

COPD (mode)

133

704

1.48

4.34

1.5

4.52

3.80

mg/l

1.20

126

679

Propionic acid derivatives

138

467

1.49

4.33

1.9

4.72

5.01

mg/l

0.26

133

446

Personal history of other diseases and conditions

258

1.90

4.32

2.8

1.8

3.78

2.86

mg/l

0.67

251

Substance abuse, excluding more controls

166

1926

0.72

4.31

1.4

1.8

4.80

3.83

mg/l

1.25

156

1849

Insulin medication

320

2079

1.28

4.30

1.9

1.8

5.73

3.64

mg/l

5.50

298

1991

Other hearing loss

163

1125

1.41

4.25

1.9

1.8

4.51

4.48

mg/l

0.02

152

1068

Shoulder lesions

392

1877

1.25

4.24

1.8

1.9

3.87

3.97

mg/l

0.15

374

1803

Other cataract

248

1396

1.32

4.23

2.3

1.7

4.86

3.92

mg/l

1.38

240

1344

Diabetes mellitus

507

2404

1.22

4.22

1.7

1.8

4.55

3.41

mg/l

5.41

480

2314

5-aminosalicylic acid

572

1.58

4.15

1.6

1.8

3.77

3.67

mg/l

0.06

553

Diabetes, varying definitions

504

2403

1.22

4.15

1.7

1.8

4.54

3.42

mg/l

5.33

477

2313

Allergic asthma (mode), excluding more controls

437

1.66

4.14

1.8

1.5

3.25

3.06

mg/l

0.21

423

Insulin, combination of fast acting with intermediate-acting or long-acting

320

2290

1.27

4.11

1.9

1.8

5.73

3.80

mg/l

4.79

298

2198

Acquired pure red cell aplasia [erythroblastopenia]

8.35

4.11

2.3

1.8

8.19

3.76

mg/l

—

Diseases of male genital organs

247

937

1.33

4.10

1.7

1.8

4.39

3.99

mg/l

0.56

238

895

Mycoses, including avohilmo

464

2897

1.22

4.09

2.0

1.8

3.90

3.77

mg/l

0.20

440

2783

Varicose veins

325

1937

1.27

4.08

2.0

1.7

4.07

3.94

mg/l

0.20

312

1850

Fracture of rib(s), sternum and thoracic spine

171

1241

1.38

4.05

2.2

1.7

4.40

4.11

mg/l

0.31

160

1188

Rash and other nonspecific skin eruption

295

1.81

4.03

1.5

1.8

3.43

4.40

mg/l

1.55

286

External causes of morbidity and mortality

314

1231

1.28

3.96

1.9

1.8

4.30

3.62

mg/l

1.49

305

1174

Dipeptidyl peptidase 4 (DPP-4) inhibitors

320

1988

1.26

3.93

1.8

5.72

3.81

mg/l

5.07

303

1910

Diseases of middle ear and mastoid

258

1629

1.29

3.87

1.9

1.8

3.98

3.67

mg/l

0.41

247

1554

Nonsuppurative otitis media

517

1.55

3.85

1.9

1.8

4.38

3.68

mg/l

0.58

496

Other inherited muscular atrophy

13.00

3.84

8.8

2.4

1.70

3.36

mg/l

—

Deforming dorsopathies

137

968

1.42

3.80

2.1

1.8

3.78

3.87

mg/l

0.09

132

921

Type 2 diabetes

491

2357

1.21

3.76

1.8

4.61

3.44

mg/l

5.48

465

2269

Molar incisor enamel hypoplasia, with caries

12.09

3.76

2.7

2.2

4.50

1.74

mg/l

—

Hyperplasia of prostate

198

830

1.35

3.69

1.9

1.8

4.06

4.07

mg/l

0.01

189

794

Injuries to the shoulder and upper arm

439

2798

1.21

3.66

2.0

1.8

4.33

3.78

mg/l

1.46

423

2681

Other retinal disorders

350

2147

1.24

3.65

1.6

1.8

5.13

3.92

mg/l

3.10

328

2058

Allergic asthma (mode)

453

1.60

3.64

1.8

1.6

3.25

3.27

mg/l

0.01

437

Lumbar disc prolapse

305

1797

1.26

3.62

1.7

1.8

3.46

3.78

mg/l

0.81

296

1719

Procreative management

140

824

1.40

3.57

1.9

1.8

3.35

3.59

mg/l

0.33

135

799

Inguinal hernia

296

1560

1.26

3.56

1.8

3.98

mg/l

0.00

284

1494

Benign thyroid growths and nodules

171

1178

1.35

3.56

1.8

1.9

3.85

3.83

mg/l

0.02

165

1125

Anosmia

4.82

3.55

1.4

2.2

2.74

2.28

mg/l

—

Diabetic retinopathy, excluding more controls

124

482

1.44

3.48

1.8

1.7

6.62

3.75

mg/l

3.32

115

462

Injuries to the hip and thigh

257

1814

1.27

3.44

1.8

4.29

4.09

mg/l

0.28

244

1728

Chorioretinal inflammation

2.37

3.42

2.2

1.7

3.03

3.60

mg/l

0.45

Use of memantine

964

0.66

3.41

1.3

1.7

4.24

4.93

mg/l

1.04

909

Use of other anti-dementia drugs

964

0.66

3.41

1.3

1.7

4.24

4.93

mg/l

1.04

909

Continuous positive airway pressure

527

1.49

3.34

1.3

1.8

5.99

3.33

mg/l

3.19

510

Fissure and fistula of anal and rectal regions

118

834

1.42

3.34

1.6

1.7

3.46

3.60

mg/l

0.15

112

801

Other ill-defined and unspecified causes of mortality

306

1.71

3.33

2.0

1.7

5.26

4.74

mg/l

0.23

295

Ovarian dysfunction, other/unspecified

8.76

3.28

1.2

1.3

2.82

2.47

mg/l

—

Seminoma of testis

8.71

3.27

1.7

1.6

4.77

2.61

mg/l

—

Type 2 diabetes, definitions combined

476

2325

1.19

3.26

1.7

1.8

4.29

3.45

mg/l

3.91

454

2241

Other and unspecified disorders of vitreous body

237

1824

1.27

3.25

1.8

3.59

3.87

mg/l

0.60

227

1753

Fall on same level

559

2535

1.18

3.23

1.8

3.95

3.67

mg/l

0.73

536

2431

Hallux valgus (acquired)

155

819

1.36

3.21

2.0

1.8

2.96

3.89

mg/l

4.53

149

787

Other benign neoplasms of connective and other soft tissue

310

1.69

3.19

1.7

1.8

3.09

4.23

mg/l

1.80

299

Acne

191

1.88

3.18

1.9

1.7

3.36

3.06

mg/l

0.12

184

Malignant neoplasm of pancreas

2.41

3.13

1.5

3.68

4.40

mg/l

0.43

Suppurative and unspecified otitis media

136

880

1.37

3.13

1.9

1.8

3.23

3.55

mg/l

0.61

129

844

Adverse effects, not elsewhere classified

613

1.47

3.12

2.1

1.8

2.91

3.87

mg/l

3.28

596

Nontoxic multinodular goitre

104

729

1.43

3.11

1.8

1.9

4.22

3.82

mg/l

0.40

104

699

Presbycusis

527

1.50

3.08

1.7

4.90

4.85

mg/l

0.03

494

Hypoplasia of dental enamel

7.57

3.05

2.7

5.8

4.50

1.75

mg/l

—

Type 2 diabetes, strict (exclude DM1)

477

2347

1.18

3.04

1.7

1.8

4.30

3.46

mg/l

3.97

455

2263

Organic, including symptomatic, mental disorders

191

1730

0.77

3.03

1.7

1.8

4.76

4.27

mg/l

0.60

177

1659

Cholecystectomy

362

2552

1.21

3.00

1.8

4.06

3.82

mg/l

0.34

344

2450

Dementia in Alzheimer disease

613

0.60

2.95

1.5

1.6

4.49

5.15

mg/l

0.63

578

Diabetic nephropathy

549

1.48

2.93

1.9

1.6

10.40

4.18

mg/l

4.68

517

Injury, poisoning and certain other consequences of external causes

253

1008

1.26

2.92

1.9

1.8

4.01

3.70

mg/l

0.55

246

961

Congenital malformations, deformations and chromosomal abnormalities

253

1929

1.24

2.90

1.8

3.84

3.54

mg/l

0.52

245

1849

Other and unspecified diseases of spleen

6.87

2.89

2.7

1.7

5.97

4.13

mg/l

—

Selective deficiency of immunoglobulin G [IgG] subclasses

5.50

2.89

1.6

1.5

6.93

3.29

mg/l

—

Abnormal involuntary movements

454

1.53

2.86

2.3

1.8

4.71

4.35

mg/l

0.21

438

Ill-defined and unknown causes of mortality

337

1.61

2.82

2.0

1.7

5.23

4.72

mg/l

0.23

323

Nonsuppurative otitis media, including avohilmo

125

794

1.36

2.81

1.9

1.8

3.95

3.67

mg/l

0.25

119

761

Drug-induced aplastic anaemia

8.94

2.80

1.0

2.2

4.30

3.87

mg/l

—

Other nonautoimmune haemolytic anaemias

8.83

2.79

2.2

1.3

3.34

5.40

mg/l

—

Kela-code for severe mental illness

1272

0.71

2.79

2.0

1.8

3.49

3.74

mg/l

0.30

1222

Chylothorax

8.77

2.78

1.2

6.26

5.22

mg/l

—

Osteomyelitis of vertebra

6.24

2.73

1.0

1.6

5.55

4.69

mg/l

—

Type 2 diabetes, definitions combined, including avohilmo

471

2325

1.17

2.72

1.8

4.30

3.42

mg/l

4.26

449

2241

Disorders of synovium and tendon

259

1784

1.23

2.72

1.6

1.8

3.33

3.77

mg/l

1.30

250

1714

Mastocytosis

6.14

2.71

1.5

1.7

1.80

3.28

mg/l

—

Excessive, frequent and irregular menstruation

152

611

1.33

2.71

2.0

1.9

3.38

3.64

mg/l

0.33

144

591

Internal derangement of knee

168

1287

1.29

2.71

1.6

1.8

3.13

3.74

mg/l

1.55

163

1229

Atopic dermatitis, strict definition with reimbursement

111

776

1.38

2.70

1.8

3.68

3.29

mg/l

0.38

104

744

Leiomyoma of uterus

278

1269

1.23

2.69

1.7

1.9

2.99

3.55

mg/l

2.57

263

1222

Abnormal serum enzyme levels

158

1171

1.30

2.69

1.8

4.86

4.21

mg/l

0.55

152

1121

Benign neoplasm of bone and articular cartilage

249

1.69

2.68

1.5

2.0

3.16

4.09

mg/l

1.46

241

Traumatic subdural haemorrhage

476

1.48

2.68

1.5

1.8

5.28

4.69

mg/l

0.44

451

Subjective visual disturbances

129

965

1.34

2.66

1.9

1.8

3.57

3.82

mg/l

0.34

123

926

Chronic gastritis

140

1060

1.32

2.66

1.4

1.8

4.25

4.20

mg/l

0.04

131

1008

Polyuria

120

889

1.35

2.65

1.5

1.8

3.53

4.33

mg/l

1.90

112

847

Cholecystitis

496

1.48

2.63

1.8

1.7

4.95

4.39

mg/l

0.36

470

Unspecified mental disorder

104

1417

0.73

2.61

1.9

1.8

3.62

3.71

mg/l

0.09

1360

COPD, hospital admissions 1, only main diagnosis

111

1287

0.74

2.59

1.4

1.8

4.67

4.38

mg/l

0.34

104

1223

Other headache syndromes

193

1525

1.26

2.58

1.7

1.9

2.89

3.66

mg/l

4.20

185

1468

Other external causes of accidental injury

385

1625

1.19

2.57

2.0

1.8

3.98

3.76

mg/l

0.42

372

1551

Other or unspecified common variable immunodeficiency

7.38

2.57

1.0

1.1

3.20

3.29

mg/l

—

Chromophobe cell carcinoma of kidney

7.29

2.56

3.2

1.4

8.74

2.71

mg/l

—

Other nutritional deficiencies

320

2442

1.20

2.56

1.6

1.8

4.35

3.48

mg/l

2.66

306

2351

Defects in the complement system

5.55

2.55

2.3

2.0

4.27

4.91

mg/l

—

Neurotic, stress-related and somatoform disorders

415

2438

1.17

2.52

1.9

1.8

3.49

3.62

mg/l

0.25

391

2352

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

102

734

1.38

2.51

2.8

1.7

3.75

3.47

mg/l

0.20

706

Oxicams

106

435

1.39

2.51

1.8

3.91

5.09

mg/l

1.44

417

Artificial joint operation, meniscal resection

468

2577

1.16

2.50

1.8

3.56

3.98

mg/l

1.87

447

2476

Left ventricular outflow tract obstruction, narrow definition

129

1.95

2.50

1.6

1.9

3.88

3.87

mg/l

0.01

124

Fracture of femur

139

956

1.31

2.49

2.0

1.8

4.87

4.59

mg/l

0.25

133

912

Polycystic ovarian syndrome, consortium definition

304

1447

1.21

2.47

2.0

1.9

3.12

3.39

mg/l

0.84

288

1393

Anti-inflammatory and antirheumatic products, non-steroids

125

467

1.35

2.45

1.9

4.42

5.01

mg/l

0.65

119

446

Viral warts, including avohilmo

680

1.39

2.43

1.9

1.8

3.72

3.76

mg/l

0.02

653

Type of accident

138

1061

1.30

2.39

1.9

1.8

4.38

3.82

mg/l

0.56

129

1023

Insulin, intermediate and long-acting

272

2178

1.21

2.39

1.8

5.93

3.84

mg/l

4.30

252

2088

Other or unspecified immunodeficiency

6.42

2.39

1.2

2.1

3.14

3.69

mg/l

—

Disorders of adrenal gland, other and/or unspecified

6.37

2.38

1.2

1.8

4.26

2.96

mg/l

—

Atopic dermatitis, strict definition

107

776

1.35

2.37

1.9

1.8

3.72

3.46

mg/l

0.23

101

746

Benign neoplasm: Colon, unspecified

136

1046

1.30

2.36

1.8

1.7

3.94

4.23

mg/l

0.40

127

1005

Benign neoplasm: Transverse colon

418

1.49

2.36

1.6

1.9

3.95

4.42

mg/l

0.40

403

Other and unspecified nerve root and plexus disorders, also in other diseases

103

762

1.36

2.34

2.0

1.9

3.39

3.92

mg/l

0.54

734

Disorders of vestibular function (Vertigo)

240

1923

1.22

2.32

1.8

3.75

3.98

mg/l

0.24

219

1846

Other neurological diseases

372

2463

1.17

2.31

1.8

3.93

3.98

mg/l

0.07

354

2364

Vascular disorders of the intestines

207

1.70

2.30

1.9

1.6

6.59

3.99

mg/l

1.61

200

Irritable bowel syndrome

124

946

1.31

2.29

1.7

1.8

3.18

3.53

mg/l

0.66

114

912

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

462

1.46

2.29

1.5

1.8

4.80

4.14

mg/l

0.47

449

Intracranial injury

286

2232

1.19

2.28

2.1

1.8

3.91

3.87

mg/l

0.07

270

2133

Other chronic obstructive pulmonary disease, including avohilmo

205

2064

0.81

2.26

1.5

1.9

4.35

4.14

mg/l

0.33

194

1981

Antenatal screening

316

0.60

2.26

2.3

1.9

3.25

2.74

mg/l

0.33

308

Supplementary factors related to causes of morbidity and mortality classified elsewhere

146

1141

1.28

2.26

1.9

1.8

4.61

3.81

mg/l

0.89

137

1095

Cardiac arrest

150

1.76

2.25

1.3

1.6

6.55

3.23

mg/l

1.08

143

Diabetic retinopathy

159

773

1.28

2.25

1.8

1.7

6.58

4.42

mg/l

2.12

147

737

Symptoms and signs involving speech and voice

169

1346

1.26

2.24

1.7

1.8

3.58

4.05

mg/l

0.80

161

1286

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

453

2329

1.15

2.24

1.6

1.8

4.68

3.45

mg/l

5.45

430

2244

Anxiety disorders

417

2468

1.16

2.24

1.9

1.8

3.52

3.61

mg/l

0.16

393

2380

Restrictive cardiomyopathy

5.73

2.23

5.4

1.3

3.58

3.00

mg/l

—

Gonarthrosis,primary

468

2454

1.15

2.22

1.8

3.74

3.96

mg/l

0.55

452

2354

Preparatory care for dialysis

150

1.81

2.20

2.1

1.9

16.83

4.65

mg/l

6.03

145

Ulcerative colitis

109

822

1.33

2.20

1.8

3.93

3.82

mg/l

0.09

103

794

Nontoxic goitre/thyroid nodule

146

1146

1.28

2.19

1.7

1.8

3.78

3.90

mg/l

0.13

141

1100

Diseases of inner ear

276

2216

1.19

2.18

1.8

3.70

3.97

mg/l

0.34

254

2131

Muscular dystrophy

3.75

2.16

3.4

1.4

2.17

3.74

mg/l

—

Schizophrenia

501

0.60

2.15

2.4

1.8

2.74

3.96

mg/l

4.06

485

Voice disturbances

133

1035

1.29

2.15

1.7

1.8

3.43

3.99

mg/l

0.99

127

991

IBD patients in KELA-register

722

1.35

2.14

1.5

1.8

3.55

3.79

mg/l

0.20

700

Alzheimer disease, excluding more controls

523

0.68

2.14

1.4

1.8

4.04

4.51

mg/l

0.49

496

Allergic urticaria

227

1.64

2.14

1.8

3.74

3.73

mg/l

0.00

220

Psoriatic and enteropathic arthropathies

322

1.53

2.13

1.6

1.8

2.77

3.86

mg/l

3.69

311

Other specified/unspecified soft tissue disorders

152

1.79

2.12

1.7

1.8

4.37

4.03

mg/l

0.15

147

Obesity and other hyperalimentation

297

2365

1.18

2.11

1.6

1.8

4.38

3.48

mg/l

2.59

283

2279

Later onset COPD, excluding more controls

484

1.37

2.10

1.5

4.74

4.18

mg/l

0.62

462

Inflammatory bowel disease

142

1118

1.27

2.09

1.7

1.9

3.92

3.72

mg/l

0.20

132

1082

Obesity

295

2354

1.18

2.09

1.6

1.8

4.38

3.48

mg/l

2.59

281

2268

Oter anti-inflammatory and antirheumatic agents, non-steroids

103

421

1.35

2.09

1.6

1.9

3.83

5.04

mg/l

2.37

403

Insulin, fast-acting

167

1340

1.25

2.09

1.9

1.8

6.11

3.77

mg/l

2.72

154

1282

Dentofacial anomalies [including malocclusion]

307

2039

1.18

2.09

1.9

2.92

3.54

mg/l

2.69

291

1965

Malignant neoplasm of other and unspecified major salivary glands, including Hilmo

5.07

2.08

1.2

1.5

2.50

4.06

mg/l

—

Benign neoplasm: Rectum, anus and anal canal

108

822

1.32

2.07

1.4

1.8

4.76

4.29

mg/l

0.34

103

784

Other and unspecified primary disorders of muscles

3.56

2.07

3.0

1.5

2.29

4.27

mg/l

—

Asthma/COPD (KELA code 203)

445

2596

1.15

2.05

1.5

1.9

3.80

mg/l

0.00

428

2491

Accidents

377

1625

1.16

2.04

1.9

1.8

3.97

3.76

mg/l

0.39

364

1551

Benign paroxysmal vertigo

149

1186

1.26

2.02

1.6

1.8

3.68

4.10

mg/l

0.67

136

1144

Later onset COPD

1018

0.76

2.01

1.4

1.8

5.13

4.63

mg/l

0.51

964

Depression or dysthymia

331

1544

1.17

2.00

1.8

4.01

4.00

mg/l

0.01

317

1492

Noninflammatory disorders of female genital tract

154

611

1.27

1.99

1.7

1.9

3.64

mg/l

0.01

147

591

Irregular menses

186

1138

1.23

1.97

2.1

1.9

2.91

3.16

mg/l

0.53

176

1098

Other/unspecified enthesopathies, not elsewhere classified

272

1.55

1.97

1.7

1.8

3.08

4.36

mg/l

2.40

265

Exposure to other and unspecified inanimate mechanical forces

217

1.62

1.97

1.7

1.8

3.75

4.39

mg/l

0.39

211

Cerebrovascular diseases

385

2317

1.15

1.96

1.8

4.24

3.98

mg/l

0.52

368

2222

Other mycoses, not elsewhere classified/unspecified

4.66

1.95

1.6

1.5

4.08

4.17

mg/l

—

Urticaria due to cold and heat

3.80

1.94

1.5

1.7

3.23

2.93

mg/l

—

Disorders of orbit

142

1.77

1.93

1.4

1.7

3.68

3.90

mg/l

0.14

137

Other aneurysm

180

1.68

1.92

1.6

7.16

4.38

mg/l

0.53

174

Excessive attrition of teeth

276

2325

1.18

1.91

2.0

1.8

3.64

3.50

mg/l

0.18

265

2236

Other disorders of pigmentation

143

1.76

1.89

2.0

1.5

3.47

4.28

mg/l

0.35

136

Autoimmune hepatitis

3.22

1.89

2.9

1.2

3.13

3.33

mg/l

—

Benign neoplasm: Rectum

722

1.32

1.87

1.4

1.8

5.00

4.33

mg/l

0.45

691

Paralytic strabismus

236

1.58

1.87

1.6

1.8

7.37

4.60

mg/l

0.65

229

Migraine

208

1343

1.21

1.87

2.0

1.9

2.84

3.47

mg/l

2.15

201

1292

Glucosamine medication

243

1634

1.19

1.86

1.7

1.8

3.94

4.29

mg/l

0.70

229

1566

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

274

2128

1.17

1.85

1.8

3.77

3.56

mg/l

0.35

266

2040

Acute inflammation of orbit

3.59

1.85

1.8

1.7

3.23

5.01

mg/l

—

Inflammatory bowel disease, strict (require KELA)

741

1.31

1.84

1.5

1.8

3.55

3.85

mg/l

0.26

718

Other abnormal uterine and vaginal bleeding

529

1.32

1.84

2.0

1.9

3.19

3.77

mg/l

1.25

513

Allergic conjunctivitis

243

1976

1.18

1.83

1.7

1.9

3.38

3.54

mg/l

0.25

227

1906

Other benign neoplasms of skin

184

1519

1.21

1.82

2.0

1.8

3.38

4.08

mg/l

2.94

178

1452

Biological medication for rheuma

545

1.36

1.80

1.6

1.8

2.78

3.78

mg/l

3.35

530

Carpal tunnel syndrome

297

2213

1.16

1.80

1.8

3.79

3.74

mg/l

0.07

286

2126

Lung diseases due to external agents

486

1.38

1.80

1.8

1.7

3.92

4.64

mg/l

1.17

461

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

230

1857

1.19

1.79

1.7

1.8

3.36

3.50

mg/l

0.21

215

1792

Major coronary heart disease event excluding revascularizations

306

1736

1.16

1.79

1.8

4.82

3.97

mg/l

2.07

289

1668

Corneal ulcer

606

1.34

1.79

1.6

1.7

3.69

4.03

mg/l

0.40

587

Acetic acid derivatives and related substances

114

457

1.29

1.76

1.7

1.8

4.28

5.04

mg/l

0.85

107

437

Ulcer of oesophagus

240

1.55

1.76

1.5

1.7

4.81

4.62

mg/l

0.05

231

Benign lipomatous neoplasm

143

1155

1.24

1.76

1.5

1.8

4.11

3.96

mg/l

0.15

133

1107

Acute myringitis

3.38

1.75

7.5

1.6

2.77

3.72

mg/l

—

3.38

1.75

2.0

1.4

4.70

2.94

mg/l

—

Other papulosquamous disorders

2.53

1.75

2.7

1.7

6.81

4.09

mg/l

—

Other and unspecified effects of external causes

112

880

1.27

1.74

1.9

1.8

3.09

3.74

mg/l

1.43

105

849

Dislocation, sprain and strain of joints and ligaments of knee

203

2184

0.84

1.73

1.7

1.9

2.99

3.52

mg/l

2.32

197

2096

Artrosis, including avohilmo

394

1891

1.14

1.73

1.7

1.8

4.03

3.88

mg/l

0.25

378

1817

Crohn disease

397

1.41

1.72

1.4

1.8

4.56

3.99

mg/l

0.27

387

Diabetes, insulin treatment (Kela reimbursement)

487

2577

1.12

1.72

1.6

1.8

4.67

3.53

mg/l

5.18

461

2479

Rotator cuff syndrome

302

1797

1.16

1.69

1.7

1.9

3.90

3.96

mg/l

0.08

292

1726

Sulfonylureas

119

1184

0.80

1.69

1.8

5.28

4.18

mg/l

1.63

113

1126

Unspecified human immunodeficiency virus [HIV] disease

2.83

1.65

1.0

1.6

3.27

4.74

mg/l

—

Schizoaffective disorder

212

0.47

1.63

2.8

1.8

2.95

3.96

mg/l

—

206

Insulin, fast-acting or short human

167

1385

1.21

1.60

1.9

1.8

6.11

3.88

mg/l

2.51

154

1324

Presence of cardiac and vascular implants and grafts

214

1331

1.18

1.60

1.4

1.7

4.55

4.15

mg/l

0.59

204

1276

Eustachian salpingitis and obstruction

198

1.57

1.59

1.6

1.9

5.63

3.36

mg/l

0.86

190

Dental pulpitis, including avohilmo

416

2365

1.13

1.57

1.9

1.8

3.51

3.58

mg/l

0.12

401

2274

Cervical disc disorders

163

1354

1.21

1.56

2.2

1.8

3.72

3.81

mg/l

0.11

155

1294

Urolithiasis

157

1300

1.21

1.56

1.5

1.7

4.10

mg/l

0.00

149

1243

Retinal detachments and breaks

185

1556

1.19

1.55

1.8

4.85

3.94

mg/l

0.92

177

1488

COPD, early/later onset

175

1749

0.84

1.54

1.4

1.8

4.48

4.25

mg/l

0.30

165

1677

Disorders of phosphorus metabolism and phosphatases

3.39

1.53

3.0

1.3

3.14

3.67

mg/l

—

Disorders of pituitary gland, other and/or unspecified

3.38

1.53

1.2

1.3

2.52

3.38

mg/l

—

Congenital malformations of aortic and mitral valves

115

1.75

1.52

1.5

2.0

3.74

3.81

mg/l

0.03

110

Malignant neoplasm of vulva, including Hilmo

3.36

1.52

1.2

1.3

3.88

4.33

mg/l

—

COPD related to multimorbidity

149

1520

0.83

1.52

1.4

1.8

4.56

4.33

mg/l

0.31

139

1452

Carcinoma in situ of skin of other and unspecified parts of face

315

1.43

1.52

1.8

1.7

4.28

4.88

mg/l

0.66

302

Unspecified human immunodeficiency virus [HIV] disease, including avohilmo

2.62

1.52

1.0

1.6

3.27

4.64

mg/l

—

Psoriasis vulgaris

668

1.29

1.51

2.0

1.8

3.13

4.14

mg/l

3.55

647

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

135

1106

1.22

1.50

1.5

1.8

4.22

3.76

mg/l

0.51

125

1058

Anxiety disorders, excluding more controls

395

2241

1.13

1.49

1.9

1.8

3.52

3.63

mg/l

0.19

373

2159

Diabetes medication

487

2556

1.11

1.48

1.6

1.8

4.63

3.46

mg/l

5.23

461

2458

Other disorders of eye and adnexa

470

1.34

1.47

1.5

1.8

3.44

3.82

mg/l

0.42

456

Acute laryngitis and tracheitis

255

1.47

1.8

3.75

3.35

mg/l

0.24

247

Calculus of kidney and ureter

144

1193

1.21

1.44

1.6

1.8

3.99

4.14

mg/l

0.17

136

1144

COPD, hospital admissions

174

1734

0.84

1.44

1.4

1.8

4.50

4.26

mg/l

0.32

164

1663

Other mosquito-borne viral fevers, including avohilmo

2.76

1.44

1.3

1.6

4.13

4.46

mg/l

—

Other juvenile arthritis

1.93

1.44

1.8

2.25

3.06

mg/l

1.27

Chronic rhinitis, nasopharyngitis and pharyngitis

144

1197

1.20

1.40

1.7

1.8

3.54

3.71

mg/l

0.26

139

1143

Sixth [abducent] nerve palsy

111

1.72

1.39

1.5

1.8

7.54

3.98

mg/l

0.43

106

Disorders of breast

150

1574

0.84

1.38

1.7

1.9

2.88

3.45

mg/l

2.35

142

1517

Other disorders of eyelid

222

1809

1.16

1.37

1.8

3.61

4.16

mg/l

1.91

213

1721

Colonic or urogenital fistula

123

1010

1.22

1.37

1.6

1.8

3.76

4.05

mg/l

0.30

116

969

Degeneration of macula and posterior pole

253

1700

1.15

1.36

1.7

1.8

4.85

4.14

mg/l

1.25

238

1628

Juvenile arthritis (FINNGEN)

1.84

1.35

1.8

2.35

3.09

mg/l

1.08

Intrahepatic Cholestasis of Pregnancy (ICP)

151

1.59

1.34

1.7

1.8

2.42

2.81

mg/l

0.60

146

Disorders of ocular muscles, binocular movement, accommodation and refraction

205

1749

1.16

1.34

1.8

4.55

3.59

mg/l

1.11

197

1670

Primary coxarthrosis, bilateral

149

1252

1.19

1.31

1.5

1.8

3.89

4.36

mg/l

0.90

141

1195

Other disorders of conjunctiva

524

1.30

1.31

1.9

1.8

4.28

4.22

mg/l

0.04

505

Migraine without aura

515

1.30

2.1

1.8

3.24

3.16

mg/l

0.05

494

Fall on same level involving ice and snow

212

2442

0.87

1.30

1.6

1.8

4.04

3.71

mg/l

0.40

201

2346

Serous carcinoma of ovary, including Hilmo

2.36

1.29

1.3

1.7

6.13

4.50

mg/l

—

Melanoma in situ

169

1.55

1.29

1.7

2.0

3.98

4.63

mg/l

0.31

163

Glaucoma

288

2163

1.13

1.27

1.8

3.79

4.14

mg/l

0.84

274

2067

Spontaneous abortion

134

1073

0.83

1.26

1.7

1.9

3.26

3.18

mg/l

0.08

129

1037

Early lumbar disc prolapse operation

255

0.59

1.26

1.7

1.8

2.45

3.27

mg/l

0.82

249

Hernia of abdominal wall

218

1901

1.15

1.23

1.8

4.64

3.87

mg/l

1.42

213

1813

Leisure time condition

618

1.26

1.22

1.6

1.8

4.02

4.03

mg/l

0.00

595

Pyogenic arthritis

204

1.48

1.22

3.0

1.8

8.04

4.14

mg/l

1.54

197

Alcoholic liver disease

372

0.67

1.20

1.4

1.7

6.02

4.37

mg/l

0.62

361

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

156

1.54

1.20

1.7

1.8

2.42

2.65

mg/l

0.32

151

Alcohol withdrawal state with delirium

212

0.56

1.18

1.2

1.7

3.53

4.72

mg/l

0.71

206

Fracture of lower leg, including ankle

203

2280

0.87

1.16

1.8

3.76

3.73

mg/l

0.03

197

2188

Fracture of neck

207

1.45

1.15

2.1

1.8

4.00

4.77

mg/l

0.59

202

Periapical abscess

212

1856

1.14

1.15

2.0

1.8

3.91

3.66

mg/l

0.36

207

1784

Epilepsy

132

1111

1.19

1.14

1.7

1.8

4.40

3.99

mg/l

0.38

127

1062

Bicuspidal aortic valve syndrome

103

1.66

1.13

1.6

3.26

4.00

mg/l

0.74

Deviated nasal septum

149

1273

1.17

1.11

1.8

1.7

4.20

3.87

mg/l

0.40

143

1222

Selective serotonin reuptake inhibitors

464

2202

1.10

1.8

3.80

3.96

mg/l

0.30

435

2124

Right hemicolectomy

201

1.45

1.10

1.7

1.8

5.28

4.75

mg/l

0.21

196

Ehlers-Danlos syndrome

2.40

1.09

1.4

2.2

5.86

3.57

mg/l

—

Achilles tendinitis

346

1.33

1.09

1.9

1.7

3.14

4.08

mg/l

1.90

334

Alzheimer’s disease (Atypical or mixed)

370

0.69

1.08

1.4

1.6

4.22

5.34

mg/l

0.69

352

Acute and transient psychotic disorders

350

0.68

1.06

2.6

1.8

5.39

3.93

mg/l

0.34

341

Other epidermal thickening

145

1.52

1.06

1.6

6.82

4.30

mg/l

0.53

139

Pollen allergy

473

1.27

1.05

1.9

1.8

2.92

3.31

mg/l

0.39

458

Acute appendicitis, no complications

230

2030

1.13

1.02

1.8

3.32

3.58

mg/l

0.50

224

1947

Open wound of head

254

2130

1.12

1.02

1.6

1.8

4.11

3.93

mg/l

0.30

240

2038

Statin medication

296

1496

1.11

1.02

1.8

1.9

4.31

3.46

mg/l

1.91

286

1439

Charcot foot

1.90

1.01

1.6

1.4

13.88

3.64

mg/l

—

Alzheimer’s disease (Atypical or mixed), excluding more controls

277

0.70

1.01

1.4

1.6

4.22

4.77

mg/l

0.28

257

Other problems related to primary support group, including family circumstances

257

1.36

1.00

3.1

1.7

2.88

3.27

mg/l

0.34

249

Chronic hepatitis NAS

2.01

1.00

1.6

1.7

4.96

4.00

mg/l

—

Acute appendicitis

303

2539

1.11

1.00

1.9

1.8

3.76

3.61

mg/l

0.25

294

2435

Cystic disease of liver

2.20

0.98

1.4

1.7

6.58

4.33

mg/l

—

Disorders of refraction and accommodation

110

926

1.18

0.98

2.0

1.8

4.32

3.52

mg/l

0.75

105

888

Persistent delusional disorders

236

0.63

0.97

2.7

1.8

2.93

4.27

mg/l

3.39

230

Other (not insulin) diabetes medications

461

2491

1.09

0.96

1.6

1.8

4.40

3.51

mg/l

3.74

438

2398

Endometriosis

121

597

1.18

0.96

1.8

1.9

3.27

3.63

mg/l

0.45

113

578

Cholangitis (primary sclerosing, PSC), with reimbursement 202

1.77

0.94

1.8

1.5

3.12

3.17

mg/l

—

Stroke, including SAH

317

2064

1.10

0.94

1.8

4.40

4.07

mg/l

0.56

299

1984

Visual field defects

286

1.33

0.93

2.1

1.7

3.04

4.29

mg/l

2.94

279

Vitamin deficiency

142

1.48

0.92

1.4

2.0

4.55

3.83

mg/l

0.24

137

Vitamin deficiency, wide

142

1.48

0.92

1.4

2.0

4.55

3.83

mg/l

0.24

137

Otorrhagia

2.17

0.92

1.2

1.5

5.78

3.23

mg/l

—

Contact with other sharp object(s)

171

0.58

0.91

1.4

1.7

2.19

3.82

mg/l

—

166

Human immunodeficiency virus [HIV] disease

1.91

0.88

1.0

1.8

3.40

4.08

mg/l

—

Nasal polyp

729

1.20

0.88

1.6

3.49

4.07

mg/l

0.76

692

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

871

0.83

0.88

2.1

1.7

3.78

3.48

mg/l

0.18

839

Myocardial infarction

233

1461

1.11

0.87

1.7

1.8

4.79

3.88

mg/l

2.14

221

1408

Human immunodeficiency virus [HIV] disease, including avohilmo

1.87

0.87

1.0

1.8

3.40

4.10

mg/l

—

Excessive earwax

308

2545

1.10

0.87

1.7

1.8

3.80

3.96

mg/l

0.21

297

2436

Poor fetal growth

246

1.34

0.87

1.5

1.8

2.15

2.66

mg/l

1.41

236

Ovarian dysfunction

136

1.47

0.86

1.4

1.7

2.66

2.47

mg/l

0.27

130

Falls/tendency to fall

481

2233

1.08

0.86

1.9

1.8

3.93

3.67

mg/l

0.63

461

2138

Bullous disorders

195

1.39

0.86

2.3

1.7

3.16

4.48

mg/l

2.27

190

Hallux rigidus

481

0.77

0.85

1.3

1.8

3.49

4.07

mg/l

0.62

464

Nonalcoholic steatohepatitis

1.95

0.84

2.3

1.5

2.82

3.42

mg/l

—

Myocardial infarction, without ST-elevation

197

1588

1.12

0.84

1.6

1.8

4.94

4.32

mg/l

0.96

185

1513

1.75

0.82

1.1

1.9

4.20

2.56

mg/l

—

Macular cyst

113

1.51

0.82

1.2

1.8

5.01

4.62

mg/l

0.12

108

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

1.88

0.82

1.5

1.7

4.15

3.66

mg/l

—

Unstable angina pectoris

178

1244

1.12

0.81

1.9

1.8

4.83

4.10

mg/l

1.01

171

1191

Carcinoma in situ of skin of ear and external auricular canal

1.71

0.81

1.1

1.7

3.35

5.66

mg/l

—

Appendicitis, broad definition

322

2652

1.09

0.80

1.8

3.91

3.67

mg/l

0.42

312

2543

Contact with other specified venomous animals

0.00

0.79

0.0

1.9

—

3.67

—

Caries of enamel

440

2674

1.08

0.79

1.8

3.48

3.73

mg/l

0.49

422

2575

Sequelae of injuries of head

151

0.59

0.78

1.7

1.8

2.76

4.37

mg/l

—

145

Coxarthrosis, primary, with hip surgery

235

1977

1.10

0.77

1.5

1.8

4.06

4.19

mg/l

0.21

223

1889

Psoriasis

124

1084

1.15

0.77

1.8

3.19

3.96

mg/l

3.68

114

1041

Other vitreous opacities

140

1.43

0.77

3.3

2.0

4.60

4.15

mg/l

0.13

135

Unspecified fall

229

2038

1.10

0.77

2.0

1.8

4.26

3.90

mg/l

0.57

214

1945

Diseases of appendix

324

2668

1.09

0.76

1.8

3.89

3.67

mg/l

0.38

314

2559

Use of selegiline

161

0.62

0.75

1.8

2.0

2.92

4.65

mg/l

—

156

Papulosquamous disorders

178

1596

1.12

0.75

1.9

1.8

3.30

3.89

mg/l

1.99

166

1526

Use of teriflunomide

2.10

0.74

1.0

1.8

2.02

3.25

mg/l

—

Other noninflammatory disorders of uterus, except cervix

500

1.18

0.74

1.9

4.35

3.86

mg/l

0.42

483

Presbyopia

245

1.31

0.73

1.9

1.7

3.97

3.87

mg/l

0.03

238

Stroke, excluding SAH

299

1984

1.09

0.73

1.9

1.8

4.45

4.11

mg/l

0.53

281

1905

severe traumatic brain injury, does not include concussion

847

1.16

0.72

1.7

4.76

4.60

mg/l

0.13

809

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

242

0.70

0.72

1.3

1.8

6.80

3.43

mg/l

0.87

231

Congenital malformations of the circulatory system

421

1.22

0.72

1.6

1.9

3.91

4.15

mg/l

0.16

408

Other menopausal disorders

530

0.85

0.71

1.6

1.9

2.55

3.74

mg/l

5.75

513

Other chronic obstructive pulmonary disease

174

1582

0.90

0.71

1.4

1.8

4.49

4.25

mg/l

0.31

164

1512

Viral hepatitis, including avohilmo

203

1.33

0.70

1.9

1.6

4.26

3.83

mg/l

0.19

198

Ménière disease

336

1.25

0.70

1.8

1.9

3.39

4.37

mg/l

1.62

326

Benign neoplasm: Short bones of upper limb

1.72

0.70

2.4

1.7

1.96

3.82

mg/l

—

Misadventures to patients during surgical and medical care

500

1.20

0.69

1.8

1.7

5.35

4.07

mg/l

0.75

482

Triptan medication for migraine, min. 3 purchases

203

1378

1.10

0.66

2.0

1.9

2.63

3.35

mg/l

5.27

196

1327

Psychiatric diseases

468

2198

1.07

0.66

1.9

1.8

3.86

3.80

mg/l

0.11

444

2119

Phakomatoses, not elsewhere classified

1.79

0.66

1.0

1.7

3.80

4.69

mg/l

—

Mixed disorders of conduct and emotions, excluding more controls

1.79

0.66

1.4

2.3

2.06

2.30

mg/l

—

Lactose intolerance

1.58

0.65

1.6

1.5

4.05

3.06

mg/l

0.38

Coxarthrosis, primary

299

2300

1.08

0.64

1.6

1.8

3.86

4.14

mg/l

0.69

285

2204

Abscess of anal and rectal regions

246

0.73

0.62

1.5

1.7

2.58

3.60

mg/l

2.60

241

Ischaemic Stroke, excluding all haemorrhages

277

1886

1.08

0.62

1.9

1.8

4.61

4.09

mg/l

0.90

261

1804

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

825

0.86

0.61

2.1

1.8

3.78

3.41

mg/l

0.23

796

Ascites

253

1.27

0.61

1.8

1.6

5.65

4.24

mg/l

0.86

245

Diabetic retinopathy, strict definition

483

1.18

0.60

1.7

1.6

8.14

4.12

mg/l

2.39

455

Cleft lip and cleft lip and palate

0.00

0.60

0.0

1.6

—

2.67

—

Scarlet fever

0.00

0.60

0.0

1.2

—

2.43

—

Other fall from one level to another

770

1.14

0.58

1.7

1.9

4.04

mg/l

0.00

740

Motor- or nonmotor-vehicle accident in traffic area

0.00

0.58

0.0

1.5

—

3.18

—

Preterm labour and delivery

780

1.14

0.58

1.9

2.89

3.24

mg/l

0.85

750

Lichen ruber planus, wide definition including periferal and oral lichen planus

905

0.87

0.57

1.8

3.29

3.95

mg/l

0.54

873

Peripheral artery disease

207

1502

1.09

0.57

1.9

1.8

5.98

4.19

mg/l

2.54

199

1428

Insomnia

347

2571

0.94

0.56

1.7

1.8

3.09

3.74

mg/l

3.18

332

2471

Vasomotor and allergic rhinitis

138

1218

1.11

0.56

1.9

1.8

3.18

3.59

mg/l

0.77

130

1169

Placenta praevia

0.55

1.2

1.7

2.26

2.96

mg/l

—

Use of biperiden

160

0.69

0.55

1.3

1.7

2.80

4.08

mg/l

1.90

155

Persons encountering health services in circumstances related to reproduction

221

1366

1.08

0.55

2.1

1.9

3.23

3.53

mg/l

0.59

211

1321

Other protozoal intestinal diseases

1.58

0.54

1.2

1.5

2.73

2.94

mg/l

—

Scar conditions and fibrosis of skin

116

1.38

0.54

1.4

1.6

5.03

3.76

mg/l

0.24

111

Single delivery by forceps and vacuum extractor

174

1.24

0.54

1.6

1.7

2.15

2.81

mg/l

1.74

167

Normal-pressure hydrocephalus

170

0.70

0.53

2.3

1.6

2.80

4.76

mg/l

5.15

165

Nonorganic sleeping disorders, excluding more controls

646

1.15

0.53

1.6

1.7

3.68

3.67

mg/l

0.01

625

Lactose intolerance, other/unspecified

1.43

0.52

1.7

1.6

4.03

3.17

mg/l

—

Lesion of ulnar nerve

470

1.17

0.52

2.0

1.7

3.63

4.09

mg/l

0.32

454

Biomechanical lesions, not elsewhere classified

170

1.30

0.51

1.7

2.0

4.92

4.30

mg/l

0.16

165

Soft tissue disorders related to use, overuse and pressure

121

1093

1.11

0.51

1.5

1.9

3.22

3.89

mg/l

2.49

114

1051

Unspecified chronic bronchitis

109

1.38

0.51

1.5

2.0

3.75

4.72

mg/l

0.59

104

Glaucoma suspect

166

1523

1.09

0.50

2.0

1.8

3.47

4.11

mg/l

1.95

160

1453

Other degenerative diseases of the nervous system

103

838

0.90

0.50

1.4

1.8

3.67

4.33

mg/l

1.11

800

Struck by thrown, projected or falling objec

145

0.69

0.50

1.6

1.9

2.52

4.28

mg/l

—

140

Injury of eye and orbit

444

1.17

0.50

2.0

1.8

3.51

3.98

mg/l

0.36

430

Other female pelvic inflammatory diseases

529

1.15

0.49

1.7

1.9

3.25

3.41

mg/l

0.16

506

Wet age-related macular degeneration

655

1.13

0.48

1.7

5.44

4.77

mg/l

0.37

618

Chronic diseases of tonsils and adenoids

290

1947

0.94

0.48

1.9

1.8

3.34

3.58

mg/l

0.51

281

1876

Adhesive capsulitis of shoulder

634

1.14

0.47

1.6

1.9

3.51

3.96

mg/l

0.50

613

Tumor necrosis factor alpha inhibitors

485

1.16

0.46

1.6

1.8

2.62

3.81

mg/l

3.88

473

Other obstetric trauma

111

1.35

0.46

1.3

1.9

1.98

2.95

mg/l

2.26

106

Lichen planus, including avohilmo

749

0.88

0.45

1.9

1.8

3.41

4.03

mg/l

0.39

719

Benign neoplasm of urinary organs

165

1.28

0.45

2.0

1.9

3.54

4.60

mg/l

1.65

159

Graves disease, strict definition

307

0.81

0.43

1.8

1.7

2.75

3.60

mg/l

0.92

299

Other congenital malformations of peripheral vascular system

1.62

0.43

1.2

1.8

2.50

3.33

mg/l

—

Infections of genitourinary tract in pregnancy

248

1.21

0.42

1.6

1.9

4.85

3.30

mg/l

0.82

239

Contracture of joint

1.57

0.42

2.0

1.7

1.76

3.64

mg/l

—

Fracture at wrist and hand level

139

1276

1.09

0.42

1.8

4.11

3.74

mg/l

0.26

134

1222

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

162

0.74

0.42

1.9

1.7

4.79

3.44

mg/l

0.32

156

Delirium, not induced by alcohol and other psychoactive substances

470

1.15

0.42

2.2

1.6

6.26

4.69

mg/l

0.78

448

Ectropion of eyelid

131

1.30

0.42

1.5

1.7

5.47

4.89

mg/l

0.23

125

Female infertility, associated with anovulation

131

1.30

0.42

2.1

1.6

3.21

2.65

mg/l

0.18

126

Inflammatory disease of cervix uteri

195

0.77

0.41

1.4

2.0

2.53

3.68

mg/l

3.64

187

Other and unspecified syphilis, including avohilmo

0.00

0.41

0.0

1.1

—

2.15

—

Benign neoplasm: Scrotum

0.00

0.41

0.0

1.5

—

5.27

—

Unspecified transport accident

0.00

0.41

0.0

1.5

—

2.78

—

Cleft lip and palate

0.00

0.41

0.0

1.9

—

2.81

—

Other specified transport accidents

0.00

0.41

0.0

1.7

—

3.14

—

Other and unspecified disorders of psychological development

0.00

0.41

0.0

3.7

—

2.57

—

ILD medications: nintedanib

0.00

0.41

0.0

1.5

—

6.08

—

Congenital malformations of spine and bony thorax, including avohilmo

0.00

0.41

0.0

1.8

—

3.79

—

Juvenile Open Angle Glaucoma

0.00

0.41

0.0

1.8

—

4.01

—

Use of fingolimod

0.00

0.40

0.0

1.8

—

3.64

—

Pedal cyclist injured in other and unspecified transport accidents

347

0.83

0.40

1.1

1.8

3.24

4.26

mg/l

1.74

338

Defect, injury or illness of neck

0.00

0.40

0.0

1.7

—

4.81

—

Endometriosis of pelvic peritoneum

413

1.15

0.40

2.0

1.8

2.44

3.45

mg/l

3.61

401

Use of dimethyl fumarate

0.00

0.40

0.0

2.1

—

3.96

—

Appendectomy

261

2347

1.06

0.39

1.7

1.8

3.32

3.58

mg/l

0.57

254

2252

Type 1 diabetes, wide definition, subgroup 1

625

1.12

0.39

1.5

1.9

6.68

3.67

mg/l

1.85

602

Diving or jumping into water causing injury other than drowning or submersion

0.00

0.39

0.0

1.6

—

2.78

—

Accidental poisoning by and exposure to other gases and vapours

0.00

0.39

0.0

1.5

—

3.79

—

Contact with blunt object, undetermined intent

0.00

0.39

0.0

1.5

—

2.97

—

Other congenital malformations of heart

0.00

0.39

0.0

1.7

—

2.85

—

Other abortion

0.00

0.39

0.0

2.0

—

2.96

—

Gender identity disorders

0.00

0.39

0.0

2.0

—

2.87

—

Inflammatory diseases of female pelvic organs

238

1534

1.06

0.38

1.9

3.26

3.40

mg/l

0.26

231

1473

Migraine without aura and triptan purchases

419

1.15

0.38

1.8

2.63

3.08

mg/l

0.66

403

Vascular dementia

312

0.83

0.38

1.4

1.5

4.55

5.27

mg/l

0.58

298

Other and unspecified mood [affective] disorders

159

0.75

0.38

1.2

1.6

3.52

3.29

mg/l

0.11

153

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

212

1749

0.94

0.38

1.9

1.8

3.46

3.57

mg/l

0.13

203

1675

Allergic rhinitis

893

1.09

0.37

1.9

1.8

2.84

3.48

mg/l

1.38

862

Other specified and unspecified strabismus

1.35

0.37

1.0

1.3

2.32

3.04

mg/l

—

Corns and callosities

216

1.21

0.36

2.2

1.7

4.40

4.36

mg/l

0.01

208

Polycystic ovarian syndrome, broad definition

198

1.21

0.36

2.0

1.7

2.94

2.56

mg/l

0.18

190

Sleep disorders

360

2591

0.96

0.36

1.7

1.8

3.25

3.73

mg/l

1.64

343

2490

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

171

1.23

0.35

1.3

1.7

4.30

3.91

mg/l

0.21

166

Gonarthrosis, primary, with knee surgery

284

2102

1.05

0.35

1.7

1.8

3.88

4.09

mg/l

0.46

274

2015

Other anxiety disorders

160

1273

1.07

0.35

1.9

1.8

3.10

3.42

mg/l

0.58

148

1224

Triptan medication for migraine, single purchase ok

297

1915

1.05

0.34

1.8

1.9

2.78

3.58

mg/l

6.39

288

1846

Migraine, single triptan purchase ok & required. ICD-code if available is included

297

1915

1.05

0.34

1.8

1.9

2.78

3.58

mg/l

6.39

288

1846

Fracture of forearm

212

2014

0.94

0.34

1.6

1.8

3.78

3.76

mg/l

0.02

201

1925

Other spirochaetal diseases, including avohilmo

129

1386

0.93

0.34

1.5

1.8

3.24

3.84

mg/l

1.98

123

1335

Benign neoplasm: Adrenal gland

293

1.16

0.33

2.0

1.8

4.66

4.33

mg/l

0.16

286

Combinations of oral blood glucose lowering drugs

116

1250

0.93

0.33

1.6

1.8

5.21

3.86

mg/l

1.05

107

1200

Alcohol-induced chronic pancreatitis

199

0.80

0.33

1.6

1.8

5.20

4.80

mg/l

0.13

194

Hordeolum and other deep inflammation of eyelid

182

1.21

0.33

1.5

1.9

3.84

3.97

mg/l

0.06

175

Injuries to the wrist and hand

423

2913

0.96

0.33

1.7

1.8

3.45

3.83

mg/l

0.89

409

2790

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

322

1.15

0.32

1.8

4.74

4.30

mg/l

0.14

314

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

266

1.17

0.32

1.7

1.9

6.24

4.32

mg/l

0.62

259

Thyrotoxicosis with toxic multinodular goitre

198

0.81

0.32

1.9

1.7

4.85

4.22

mg/l

0.18

189

155

1.22

0.31

1.9

2.76

4.59

mg/l

4.56

149

Spirochaetal infections, other/unspecified

314

1.15

0.31

1.4

1.8

3.39

4.41

mg/l

1.35

305

Ganglion

725

0.91

0.30

1.6

1.9

2.97

3.64

mg/l

1.18

701

Fall on and from stairs and steps

108

1004

1.08

0.30

1.9

1.8

3.67

3.93

mg/l

0.32

102

964

Any mental disorder

505

2445

1.03

0.29

1.9

1.8

3.74

3.78

mg/l

0.06

481

2354

Diabetic maculopathy, excluding more controls

363

1.13

0.29

1.8

9.06

4.07

mg/l

2.07

353

Non-selective monoamine reuptake inhibitors

161

1458

1.06

0.29

1.8

1.7

3.70

4.00

mg/l

0.65

151

1411

Exposure to other specified factors

320

2857

0.96

0.29

2.0

1.8

3.42

3.71

mg/l

0.78

312

2738

Emotional disorders starting during childhood or adolecense, excluding more controls

1.23

0.29

3.4

2.2

1.69

2.33

mg/l

—

Injuries to the knee and lower leg

505

2817

0.97

0.28

1.7

1.8

3.69

3.83

mg/l

0.30

486

2698

Other symptoms and signs involving cognitive functions and awareness

218

1841

1.05

0.28

1.9

4.16

4.03

mg/l

0.17

206

1768

COPD, hospital admission 2, with asthma infections

131

1199

0.94

0.28

1.5

1.8

4.82

4.41

mg/l

0.50

122

1142

Personality disorders

804

0.92

0.27

1.6

1.8

3.48

3.51

mg/l

0.02

776

COPD

192

1639

0.95

0.27

1.5

1.8

4.54

4.23

mg/l

0.46

182

1567

Nonorganic sleeping disorders

681

1.09

0.27

1.6

1.8

3.68

3.90

mg/l

0.15

660

Hyperkinetic disorders, excluding more controls

200

1.17

0.27

1.5

2.1

3.34

2.81

mg/l

0.18

191

Primary gonarthrosis, bilateral

249

1996

1.04

0.26

1.7

1.8

3.79

4.04

mg/l

0.38

240

1914

Melanocytic naevi of other and unspecified parts of face

178

1.18

0.26

1.4

1.9

5.75

3.88

mg/l

0.51

172

Laparoscopic right hemicolectomy

214

0.84

0.26

2.2

1.8

4.63

4.68

mg/l

0.01

207

Lyme disease

128

1357

0.94

0.26

1.5

1.8

3.25

3.86

mg/l

2.01

122

1306

Lyme disease, including avohilmo

128

1357

0.94

0.26

1.5

1.8

3.25

3.86

mg/l

2.01

122

1306

Central retinal artery occlusion

1.22

0.25

1.7

1.6

4.79

4.15

mg/l

—

Hyperkinetic disorders

229

1.15

0.25

1.5

1.8

3.29

2.89

mg/l

0.15

218

Lesion of plantar nerve

202

0.84

0.24

2.6

1.7

3.00

4.05

mg/l

1.30

196

Other infective otitis externa

202

0.84

0.24

2.5

1.8

4.05

4.24

mg/l

0.08

195

Systemic atrophies primarily affecting the central nervous system

142

1.20

0.24

5.5

1.8

2.19

4.68

mg/l

5.86

137

Spirochaetal infections, other/unspecified, including avohilmo

129

1364

0.95

0.24

1.5

1.8

3.24

3.86

mg/l

2.07

123

1313

Other spirochaetal diseases

129

1364

0.95

0.24

1.5

1.8

3.24

3.85

mg/l

2.04

123

1313

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

226

1.15

0.24

2.3

1.7

4.55

4.64

mg/l

0.04

216

Carcinoma in situ, bladder

133

1.21

0.24

1.5

1.8

3.34

5.00

mg/l

2.46

128

Endometriosis ASRM stages 3,4

735

0.92

0.24

2.1

1.8

3.80

3.31

mg/l

0.38

705

Myopia

360

1.11

0.23

2.7

1.8

6.20

3.47

mg/l

1.20

347

Other specified/unspecified deforming dorsopathies

1.32

0.23

2.2

1.9

2.38

4.62

mg/l

—

Other otitis externa (chronic)

218

1.15

0.23

2.4

2.0

5.95

4.42

mg/l

0.40

211

Effects of other deprivation

0.00

0.21

0.0

1.2

—

2.75

—

Pituitary-dependent Cushing's disease

0.00

0.21

0.0

2.4

—

5.59

—

Magnesium deficiency

0.00

0.21

0.0

1.7

—

3.13

—

Foreign body granuloma of skin and subcutaneous tissue

0.00

0.21

0.0

1.8

—

3.68

—

Atrioventricular septal defect

0.00

0.21

0.0

1.9

—

4.53

—

Congenital ptosis, including avohilmo

0.00

0.21

0.0

1.7

—

2.98

—

Special screening examination for infectious and parasitic diseases

411

1.08

0.21

1.4

1.7

2.75

3.23

mg/l

0.83

399

Histrionic personality disorder

0.00

0.21

0.0

1.6

—

3.36

—

Pre-eclampsia superimposed on chronic hypertension

0.00

0.21

0.0

1.6

—

2.59

—

Pectus excavatum, including avohilmo

0.00

0.21

0.0

1.4

—

2.55

—

Social disorders starting during childhood or adolecense, excluding more controls

0.00

0.21

0.0

2.7

—

2.61

—

Other and unspecified water transport accidents

0.00

0.21

0.0

1.8

—

4.37

—

Internuclear ophthalmoplegia

0.00

0.21

0.0

1.3

—

4.53

—

Abnormal findings in peritoneal fluid saliva

0.00

0.21

0.0

1.9

—

3.42

—

Congenital hydrocephalus

0.00

0.21

0.0

1.3

—

2.80

—

Open wounds involving multiple body regions

0.00

0.21

0.0

1.8

—

5.59

—

Brain astrocytoma, helper endpoint

0.00

0.21

0.0

1.6

—

3.17

—

Colour vision deficiencies

0.00

0.21

0.0

1.5

—

4.12

—

Chronic myringitis

0.00

0.21

0.0

1.5

—

3.85

—

Inhalation and ingestion of other objects causing obstruction of respiratory tract

0.00

0.21

0.0

1.5

—

4.17

—

Female genital prolapse

104

545

1.06

0.21

2.2

1.9

3.23

3.80

mg/l

1.05

528

Impacted maxillary molar

103

0.78

0.21

1.3

1.6

2.63

2.62

mg/l

—

Postmenopausal bleeding

103

508

1.06

0.21

2.0

1.9

3.80

3.89

mg/l

0.06

491

Nondiabetic hypoglycaemic coma

0.00

0.21

0.0

1.6

—

3.32

—

Exposure to ignition of highly flammable material

0.00

0.21

0.0

1.5

—

3.15

—

Toxic effect of corrosive substances

0.00

0.21

0.0

1.9

—

3.35

—

Congenital malformations of spine and bony thorax

0.00

0.21

0.0

2.0

—

4.24

—

Carcinoma in situ of uteri, other/unspecified

0.00

0.21

0.0

1.5

—

2.65

—

Other congenital malformations of male genital organs

0.00

0.21

0.0

2.6

—

3.42

—

Depression

413

2685

1.03

0.21

1.8

3.87

3.66

mg/l

0.37

394

2585

Respiratory distress of newborn

0.00

0.20

0.0

6.0

—

1.95

—

Benign neoplasm: Lower jaw bone

0.00

0.20

0.0

1.6

—

3.24

—

Familial erythrocytosis

0.00

0.20

0.0

1.7

—

4.05

—

Mild or no visual impairment, binocular

0.00

0.20

0.0

1.5

—

4.29

—

Intentional self-harm by jumping from a high place

0.00

0.20

0.0

2.1

—

4.12

—

Other and unspecified disorders of adult personality and behaviour

0.00

0.20

0.0

1.4

—

2.46

—

Other congenital malformations of male genital organs, including avohilmo

0.00

0.20

0.0

2.5

—

3.31

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

109

984

0.95

0.20

1.5

1.7

5.03

4.60

mg/l

0.52

100

936

Tinnitus

937

1.06

0.19

1.7

1.8

3.43

3.87

mg/l

0.47

896

Contraceptive management

140

934

1.05

0.19

1.9

2.93

3.46

mg/l

1.20

131

910

Congenital malformations of great arteries

1.18

0.19

1.7

2.5

5.95

3.72

mg/l

—

Mood disorders, excluding more controls

422

2416

1.03

0.19

1.8

4.02

3.76

mg/l

0.45

402

2325

Myocardial infarction, strict

203

1385

1.04

0.18

1.7

1.8

4.78

3.92

mg/l

1.92

192

1333

Disturbance of activity and attention

217

1.12

0.18

1.5

1.9

3.36

2.88

mg/l

0.16

206

Pregnancy with abortive outcome

236

1271

0.97

0.18

1.7

1.9

3.66

3.44

mg/l

0.41

224

1222

Type 1 diabetes

802

1.06

0.18

1.5

1.9

6.60

3.69

mg/l

2.26

768

Medical abortion

226

1265

0.97

0.18

1.7

1.9

3.47

3.44

mg/l

0.04

213

1217

Multiple gestation

216

0.88

0.17

1.6

1.8

2.83

2.59

mg/l

0.17

207

Mood disorders

445

2779

1.02

0.17

1.8

3.95

3.70

mg/l

0.48

424

2669

Agoraphobia

1.13

0.17

1.3

1.8

2.59

2.71

mg/l

—

Mood [affective] disorders

444

2779

1.02

0.17

1.8

3.96

3.70

mg/l

0.49

423

2669

Carcinoma in situ of other and unspecified sites

148

1.15

0.17

1.5

1.8

3.68

5.06

mg/l

1.51

142

Diabetes mellitus in pregnancy

485

0.94

0.16

1.8

1.7

3.18

2.59

mg/l

0.59

465

Other and unspecified injuries of lower leg

234

1.11

0.16

1.2

1.8

3.28

3.95

mg/l

0.89

227

Thyrotoxicosis with diffuse goitre

427

1.08

0.16

1.7

1.9

3.41

3.51

mg/l

0.09

411

Polycystic ovarian syndrome

1.20

0.16

1.6

1.7

2.48

2.17

mg/l

0.60

COPD-related respiratory insufficiency

463

0.93

0.16

1.7

1.8

5.77

4.74

mg/l

0.50

440

Chronic mastoiditis

0.78

0.15

2.0

6.20

4.32

mg/l

—

All anxiety disorders

225

1695

1.03

0.15

2.0

1.8

3.22

3.42

mg/l

0.34

207

1636

Abnormal findings in secretions and smears from cervix uteri vagina vulva

156

1187

0.97

0.14

2.0

1.9

3.26

3.11

mg/l

0.14

148

1140

Atopic dermatitis

207

1601

1.03

0.14

1.6

1.8

3.49

3.43

mg/l

0.08

198

1542

Supervision of normal pregnancy

310

0.94

0.14

1.8

1.9

2.44

2.74

mg/l

0.48

302

Injuries to the ankle and foot

277

2421

0.98

0.14

2.0

1.8

3.71

3.56

mg/l

0.24

268

2326

Persistent mood disorders

654

0.95

0.13

2.0

1.8

3.94

mg/l

0.00

632

Polypectomy (DHB20)

218

1.10

0.13

1.5

1.8

4.55

4.57

mg/l

0.01

213

Type 1 diabetes, wide definition

675

1.05

0.13

1.5

1.9

6.60

3.71

mg/l

1.78

648

135

1121

1.03

0.13

1.6

1.7

5.13

4.61

mg/l

0.44

124

1061

Mental disorders, not otherwise specified

219

1.10

0.12

1.3

1.7

4.15

3.68

mg/l

0.19

213

169

0.89

0.12

1.5

1.8

2.97

2.73

mg/l

0.08

164

Recurrent or chronic depression

150

1008

1.03

0.12

1.7

1.8

3.42

3.64

mg/l

0.24

142

979

Thyroiditis

229

1.09

0.12

1.3

1.7

4.99

3.73

mg/l

0.31

224

Transport accidents

183

1482

1.03

0.12

1.5

1.8

3.62

3.71

mg/l

0.09

173

1413

Dermatophytosis, including avohilmo

274

2627

1.02

0.12

1.9

1.8

3.40

3.77

mg/l

0.89

261

2523

Mental and behavioural disorders due to sedatives or hypnotics

178

0.90

0.11

1.4

1.7

6.27

3.84

mg/l

0.56

172

Twin gestation

209

0.91

0.11

1.6

1.7

2.83

2.59

mg/l

0.17

201

Other benign neoplasms of uterus

153

1.11

0.11

4.5

1.6

3.45

4.29

mg/l

0.48

147

Biguanides

425

2524

1.02

0.11

1.5

1.8

4.34

3.58

mg/l

2.81

402

2427

Postmenopausal atrophic vaginitis

509

0.96

0.10

1.9

2.71

3.85

mg/l

5.78

494

Fibroblastic disorders

937

1.04

0.10

1.8

3.39

4.04

mg/l

1.71

894

Complications of labour and delivery

217

1232

0.98

0.10

2.0

1.9

3.00

3.36

mg/l

0.91

208

1190

Bipolar affective disorders

554

1.05

0.10

1.8

4.83

3.62

mg/l

0.83

537

Glucagon-like peptide-1 (GLP-1) analogues

133

1294

1.03

0.10

1.5

1.9

4.27

3.52

mg/l

1.30

125

1248

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

133

1294

1.03

0.10

1.5

1.9

4.27

3.52

mg/l

1.30

125

1248

Other specified and unspecified retinal disorders

125

1.12

0.10

1.5

1.6

3.36

3.97

mg/l

0.32

120

Anxiety (asthma-related co-morbidities)

221

1714

0.98

0.10

2.0

1.8

3.23

3.42

mg/l

0.31

203

1656

Supervision of high-risk pregnancy

303

0.95

0.09

1.8

2.43

2.77

mg/l

0.78

295

Congenital malformations of eye, ear, face and neck

155

1.10

0.09

2.5

1.8

2.98

3.58

mg/l

0.60

150

Multiple delivery

204

1.08

0.08

1.5

1.6

2.93

3.51

mg/l

0.57

196

Otosclerosis

263

1.07

0.08

2.5

1.8

3.21

4.26

mg/l

1.60

257

Open wound of shoulder and upper arm

0.83

0.08

4.0

1.5

3.76

3.62

mg/l

—

Sequelae of injuries, of poisoning and of other consequences of external causes

844

1.03

0.08

2.1

1.9

3.38

3.91

mg/l

1.09

814

Impingement syndrome of shoulder

936

0.97

0.08

1.6

1.8

3.25

3.87

mg/l

1.70

903

Hydrocephalus

256

0.94

0.07

1.7

3.10

4.54

mg/l

2.63

247

844

0.97

0.07

1.9

1.7

4.75

4.73

mg/l

0.01

795

Additional codes for the location of defect, injury or illness

186

1.08

0.07

1.4

2.0

3.86

4.23

mg/l

0.17

179

Disorders of speech understanding and production

1.01

0.06

1.3

1.9

2.76

3.99

mg/l

—

Fall on and from ladder

275

1.06

0.06

1.4

1.7

3.57

4.70

mg/l

0.96

266

Primary open-angle glaucoma

131

1285

0.98

0.06

2.1

1.7

3.67

4.52

mg/l

2.49

125

1219

Deep bite

259

0.95

0.06

1.5

2.0

2.76

3.65

mg/l

1.89

253

Artificial joint re-operation

244

0.94

0.06

1.5

1.9

4.25

4.41

mg/l

0.13

236

Infections with a predominantly sexual mode of transmission, including avohilmo

112

1046

0.98

0.06

1.8

3.87

3.27

mg/l

0.62

107

1005

Personality disorders, excluding more controls

756

0.98

0.05

1.6

1.8

3.48

3.41

mg/l

0.06

732

Impotence

211

0.95

0.04

1.2

1.7

5.60

4.58

mg/l

0.24

204

Injuries to the elbow and forearm

289

2496

0.99

0.04

1.6

1.8

4.04

3.70

mg/l

0.47

275

2395

Endometriosis ASRM stages 1,2

507

1.03

0.04

2.0

1.8

2.44

3.16

mg/l

2.42

491

Postpartum haemorrhage due to anatomy

190

0.95

0.04

2.7

1.8

2.62

mg/l

0.00

184

Transient ischemic attack

236

1896

0.99

0.04

1.8

4.27

4.10

mg/l

0.16

224

1816

Diseases of external ear

143

1413

1.01

0.03

2.2

1.7

4.31

3.93

mg/l

0.37

138

1348

Foreign body entering into or through eye or natural orifice

230

1.04

0.03

1.5

1.9

3.67

4.69

mg/l

0.48

224

Non-small cell lung cancer, adenocarcinoma, helper endpoint

240

1.04

0.03

1.6

1.7

3.84

4.60

mg/l

0.69

231

Foreign body in alimentary tract

151

1.06

0.03

1.8

2.0

3.36

4.71

mg/l

1.08

145

Specific development disorders of speech and language

117

1.07

0.03

1.5

2.0

2.60

3.49

mg/l

1.14

111

Unspecified misadventure during surgical and medical care

191

1.05

0.03

1.5

2.0

5.40

4.45

mg/l

0.36

185

Excessive vomiting in pregnancy

211

1.04

0.03

1.9

1.7

2.28

3.18

mg/l

1.22

203

Other complications of labour and delivery, not elsewhere classified

185

0.96

0.02

1.8

2.39

2.67

mg/l

0.24

175

Abnormal findings on antenatal screening of mother

128

0.94

0.02

1.6

1.7

3.67

2.36

mg/l

0.34

120

Contact with heat and hot substances

142

1.06

0.02

1.3

2.0

3.69

4.00

mg/l

0.07

137

Ulcerative proctitis

172

1.05

0.02

1.3

1.8

3.96

3.90

mg/l

0.02

167

Progressive vascular leukoencephalopathy

133

1.05

0.01

1.3

1.7

3.54

5.00

mg/l

1.98

127

Atherosclerosis, excluding cerebral and coronary sclerosis

179

1413

0.99

0.01

1.9

1.8

5.95

4.22

mg/l

2.08

173

1340

Foreign body in respiratory tract

144

1.04

0.00

1.7

1.9

3.01

3.92

mg/l

0.97

139

Sub-endpoint used in defining T1D endpoints

931

0.99

0.00

1.5

1.8

6.63

3.98

mg/l

2.13

894

Other peripheral vertigo

334

1.02

0.00

1.5

1.8

6.56

4.37

mg/l

0.39

325

Blepharochalasis

124

1234

1.00

0.00

1.6

1.8

3.36

4.13

mg/l

2.49

119

1179

Complications predominantly related to the puerperium

756

1.01

0.00

2.2

1.9

2.45

3.10

mg/l

2.13

725

Failed induction of labour

105

1.05

0.00

1.5

1.7

2.66

3.14

mg/l

0.38

Subarachnoid haemorrhage

364

0.99

0.00

1.2

1.7

3.80

4.47

mg/l

0.72

346

Diabetic maculopathy

375

1.01

0.00

1.8

1.6

8.85

4.02

mg/l

1.91

355

Behavioural syndromes associated with physiological disturbances and physical factors

394

2660

1.00

0.00

1.8

3.44

3.72

mg/l

0.66

375

2555

Superficial injury of lower leg

974

1.00

0.00

1.6

1.8

3.67

3.73

mg/l

0.05

936

Foreign body or object entering through skin

172

0.99

0.00

2.2

1.9

2.88

4.45

mg/l

2.05

166

Extrapyramidal and movement disorders

165

1651

1.00

0.00

2.0

1.7

3.54

4.14

mg/l

1.95

157

1576

Assault by bodily force

184

0.98

0.00

1.3

1.8

4.13

3.89

mg/l

0.06

179

Melanocytic naevi of lower limb, including hip

128

1.02

0.00

3.2

1.7

3.64

4.00

mg/l

0.15

123

Visual impairment including blindness (binocular or monocular)

209

1.00

0.00

1.3

1.7

4.97

4.29

mg/l

0.39

202

Other and unspecified syphilis

0.00

0.0

1.0

—

2.47

—

Klinefelter syndrome, karyotype 47 XXY

0.00

0.0

1.6

—

3.00

—

Congenital malformations of great veins

0.00

0.0

1.4

—

2.60

—

Complicated migraine, drug-induced

0.00

0.0

1.6

—

2.62

—

Thalassaemia

0.00

0.0

2.0

—

2.37

—

Carcinoma in situ of stomach

0.00

0.0

1.4

—

3.86

—

Spina bifida

0.00

0.0

1.6

—

3.91

—

Tetralogy of Fallot, a congenital heart defect.

0.00

0.0

1.4

—

2.42

—

Malignant neoplasm of vagina, including Hilmo

0.00

0.0

1.2

—

3.48

—

Pectus excavatum

0.00

0.0

1.5

—

2.20

—

Traumatic amputation of part of head

0.00

0.0

1.5

—

2.63

—

Drug-induced dystonia

0.00

0.0

1.6

—

3.64

—

Sequelae of injuries involving multiple and unspecified body regions

0.00

0.0

2.2

—

3.55

—

Bradycardia, unspecified, drug-induced

0.00

0.0

2.0

—

5.72

—

Supernumerary teeth EXCLUDE clefts and syndromes

0.00

0.0

1.8

—

1.94

—

Other hypertrichosis

0.00

0.0

1.8

—

4.86

—

Hyperfunction of pituitary gland, other and/or unspecified

0.00

0.0

2.3

—

4.00

—

Yaws, including avohilmo

0.00

0.0

1.5

—

3.46

—

Thyroid crisis or storm

0.00

0.0

2.0

—

3.67

—

Retained (old) intraocular foreign body

0.00

0.0

2.4

—

3.72

—

Carcinoma in situ of breast

0.00

0.0

1.3

—

3.28

—

Coccidioidomycosis, including avohilmo

0.00

0.0

2.4

—

3.72

—

Hereditary factor VIII deficiency

0.00

0.0

1.3

—

4.48

—

Congenital myopathies

0.00

0.0

1.9

—

3.23

—

Cyst of iris, ciliary body and anterior chamber

0.00

0.0

1.2

—

3.42

—

Congenital lactase deficiency

0.00

0.0

1.8

—

2.41

—

Complications specific to multiple gestation

0.00

0.0

1.4

—

2.94

—

Drug-induced myopathy

0.00

0.0

1.5

—

4.38

—

Relapsing fevers, including avohilmo

0.00

0.0

1.8

—

3.62

—

Unspecified multiple injuries

0.00

-0.00

0.0

1.1

—

2.43

—

Assault by hanging, strangulation and suffocation

0.00

-0.00

0.0

2.7

—

5.53

—

Traumatic amputation of hip and thigh

0.00

-0.00

0.0

1.2

—

6.64

—

Other congenital malformations of skull and face bones

0.00

-0.00

0.0

1.7

—

2.96

—

Disorder of bilirubin metabolism, other/unspecified

0.00

-0.00

0.0

1.4

—

4.88

—

Mental and behavioural disorders due to cocaine

0.00

-0.00

0.0

1.4

—

1.90

—

Other and unspecified neuropathies

0.00

-0.00

0.0

1.4

—

2.97

—

Kyphoscoliotic heart disease

0.00

-0.00

0.0

1.6

—

3.72

—

Ankylosis of teeth

0.00

-0.00

0.0

2.8

—

3.08

—

Need for immunization against other single infectious diseases

0.00

-0.00

0.0

1.6

—

3.20

—

Upper arm

0.00

-0.00

0.0

1.8

—

3.93

—

Disorders of glycoprotein metabolism

0.00

-0.00

0.0

1.2

—

4.83

—

Other injuries involving multiple body regions, not elsewhere classified

0.00

-0.00

0.0

1.6

—

3.30

—

Injury of muscle and tendon at forearm level

1.00

-0.00

1.2

1.5

2.54

3.55

mg/l

—

Brain mixed glioma, helper endpoint

0.00

-0.00

0.0

1.5

—

2.17

—

Frostbite involving multiple body regions and unspecified frostbite

0.00

-0.00

0.0

2.0

—

3.29

—

Crushing injury and traumatic amputation of part of abdomen, lower back and pelvis

0.00

-0.00

0.0

1.8

—

2.88

—

Pneumoconiosis due to asbestos and other mineral fibres

0.86

-0.00

1.0

1.5

3.28

5.78

mg/l

—

Female pelvic inflammatory disorders in diseases classified elsewhere

0.00

-0.00

0.0

1.7

—

2.83

—

ICD 8 haemorrhage (epidural, subarachnoid, subduralis)

0.00

-0.00

0.0

1.9

—

5.12

—

Lens-induced iridocyclitis

0.00

-0.00

0.0

2.2

—

4.56

—

Epileptic seizures related to drugs

0.00

-0.00

0.0

1.4

—

2.20

—

Lipoprotein deficiency

0.00

-0.00

0.0

1.4

—

5.76

—

Multiple superficial injuries of ankle and foot

0.00

-0.00

0.0

1.2

—

2.48

—

Accidental poisoning by and exposure to pesticides

0.00

-0.00

0.0

1.4

—

4.94

—

Family history of mental and behavioural disorders

0.00

-0.00

0.0

1.6

—

2.38

—

Urethral discharge

0.00

-0.00

0.0

2.0

—

3.05

—

Acne keloid

0.00

-0.00

0.0

1.1

—

3.04

—

Chlamydial lymphogranuloma (venereum)

0.00

-0.00

0.0

2.2

—

3.38

—

Dengue fever [classical dengue], including avohilmo

0.00

-0.00

0.0

2.0

—

3.62

—

General hospital and personal-use devices associated with adverse incidents

0.00

-0.00

0.0

1.7

—

3.90

—

Plasmodium falciparum malaria, including avohilmo

0.00

-0.00

0.0

1.8

—

3.21

—

Severe bullous disorders, KELA reimbursement

0.00

-0.00

0.0

1.8

—

6.72

—

Use of benzatropine

0.00

-0.00

0.0

2.0

—

4.40

—

Other helminthiases, including avohilmo

0.00

-0.00

0.0

1.1

—

3.06

—

Photocontact dermatitis [berloque dermatitis]

0.00

-0.00

0.0

1.4

—

3.14

—

Alopecia universalis

0.00

-0.00

0.0

1.9

—

3.48

—

Non-seminoma of testis

0.00

-0.00

0.0

1.7

—

2.42

—

Chlamydial lymphogranuloma (venereum), including avohilmo

0.00

-0.00

0.0

2.2

—

3.38

—

Other helminthiases

0.00

-0.00

0.0

1.2

—

3.88

—

Other congenital musculoskeletal deformities

0.00

-0.00

0.0

2.4

—

3.42

—

Mental and behavioural disorders due to use of volatile solvents

0.00

-0.00

0.0

1.3

—

2.09

—

Exposure to ignition or melting of other clothing and apparel

0.00

-0.00

0.0

1.9

—

3.19

—

Disorders of hypoglossal nerve

0.00

-0.00

0.0

1.4

—

4.08

—

Intermittent hydrarthrosis

0.00

-0.00

0.0

1.8

—

3.90

—

Alpha thalassaemia

0.00

-0.00

0.0

1.8

—

2.50

—

Eclampsia

0.00

-0.00

0.0

1.4

—

3.34

—

Brain astrocytoma

0.00

-0.00

0.0

1.4

—

2.52

—

Behçet disease

0.00

-0.00

0.0

1.2

—

2.06

—

Other congenital musculoskeletal deformities, including avohilmo

0.00

-0.00

0.0

2.0

—

2.91

—

Exposure to controlled fire, not in building or structure

0.00

-0.00

0.0

2.0

—

3.46

—

Bacterial sepsis of newborn

0.00

-0.00

0.0

7.7

—

2.74

—

Pedestrian injured in collision with two- or three-wheeled motor vehicle

0.00

-0.00

0.0

1.7

—

3.50

—

Non-seminoma of testis, including Hilmo

0.00

-0.00

0.0

1.4

—

2.37

—

Brain astrocytoma, including Hilmo

0.00

-0.00

0.0

1.4

—

2.52

—

Multiple congenital exostoses, including avohilmo

0.00

-0.00

0.0

1.8

—

3.38

—

Disorders of copper metabolism

0.00

-0.00

0.0

1.0

—

2.54

—

Coccidioidomycosis

0.00

-0.00

0.0

2.4

—

3.72

—

Toxic encephalopathy

0.00

-0.00

0.0

1.3

—

9.28

—

Food allergy

0.00

-0.00

0.0

1.1

—

2.83

—

Other fusion of spine

0.00

-0.00

0.0

1.2

—

2.55

—

Ectopic testis

0.00

-0.00

0.0

3.4

—

2.53

—

Syndactyly

0.00

-0.00

0.0

2.0

—

3.38

—

Reduction defects of lower limb

0.00

-0.00

0.0

2.0

—

3.26

—

Reduction defects of upper limb

0.00

-0.00

0.0

2.0

—

3.21

—

Plasmodium falciparum malaria

0.00

-0.00

0.0

1.9

—

3.40

—

Benign neoplasm: Epididymis

0.00

-0.00

0.0

1.7

—

4.36

—

Use of interferon beta-1a

1.02

-0.00

1.0

1.8

2.30

3.40

mg/l

—

Benign neoplasm: Penis

0.00

-0.00

0.0

1.4

—

2.34

—

Benign neoplasm: Ribs, sternum and clavicle

0.00

-0.00

0.0

1.7

—

3.39

—

Motor- or nonmotor-vehicle accident, type of vehicle unspecified - non-traffic accident

0.00

-0.00

0.0

2.2

—

3.42

—

Polyhydramnios

0.98

-0.00

1.3

1.7

2.69

2.58

mg/l

—

Other and unspecified disorders of globe

0.00

-0.00

0.0

1.9

—

4.24

—

Other congenital malformations of digestive system

0.00

-0.00

0.0

2.4

—

4.58

—

Other congenital malformations of brain

0.00

-0.00

0.0

2.0

—

3.13

—

Congenital ptosis

0.00

-0.00

0.0

1.8

—

3.06

—

Cleft lip

0.00

-0.00

0.0

1.8

—

2.74

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS